UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

~~(Mark~~[X] ~~One~~QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

xFor the ~~Annual~~fiscal ~~Report~~year ~~Pursuant~~ended toDecember ~~Section~~31, ~~13 or 15(d) of The Securities Exchange Act of 1934~~2017

~~For~~[ ~~the~~] ~~Fiscal~~TRANSITION ~~Year~~REPORT ~~Ended~~PURSUANT ~~December~~TO ~~31,~~SECTION ~~2016~~13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

oFor the ~~Transition~~transition ~~Report~~period ~~Pursuant~~from _____ to ~~Section 13 or 15(d) of The Securities Exchange Act of 1934~~______

~~For~~Commission File ~~the~~Number ~~transition period from _______________ to _______________~~000-54001

Commission File Number: 000-54001

PROTECT PHARMACEUTICAL CORPORATION

(Exact name of registrant as specified in its charter)

Nevada	~~27-1877179~~	27-1877179
(State or other jurisdiction of	(I.R.S. Employer
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
incorporation or organization)	Identification No.)

95 Merrick Way, Third Floor, Coral Gables, Florida 33143

(Address of principal executive offices) ~~(Zip Code)~~

~~Registrant's telephone number, including area code:~~ (954) 292-0033

~~Securities~~(Registrant’s telephone ~~registered~~number, ~~pursuant~~including toarea ~~Section 12(b~~code) ~~of the Act:~~

~~None~~Securities registered pursuant to section 12(g) of the Act:

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $0.005 par value

~~Indicate~~Preferred Class byA, ~~check~~same ~~mark~~par ifas ~~the~~common, ~~registrant is a well-known seasoned issuer~~1,000 asvotes ~~defined~~per ~~in Rule 405 of the Securities Act~~share.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ¨ [ ] No [X]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).Yes [ ] No x [X]

Indicate by check mark ifwhether the registrant is ~~not~~a ~~required~~large toaccelerated ~~file~~filer, ~~reports~~an ~~pursuant~~accelerated tofiler, ~~Section~~a 13non-accelerated filer, a smaller reporting company or ~~Section~~an ~~15(d)~~emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

~~Yes ¨~~Large accelerated file [ ] Accelerated filer [ ] Non-Accelerated filer [ ] Smaller reporting company [X] Emerging growth company [ ]

~~No x~~If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company x (Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes x [X] No ¨ [ ]

~~The~~APPLICABLE ONLY ~~aggregate~~TO ~~market~~CORPORATE value of the voting stock held by non-affiliates of the registrant based on the closing sales price, or the average bid and asked price on such stock, as of June 30, 2016, the last business day of the registrant’s most recently completed second quarter, was $104,638. Shares of the registrant’s common stock held by each executive officer and director and by each entity or person that, to the registrant’s knowledge, owned 10% or more of registrant’s outstanding common stock as of June 30, 2016 have been excluded in that such persons may be deemed to be affiliates of the registrant. This determination of affiliate status is not necessarily a conclusive determination for other purposes.ISSUERS

~~The~~Indicate the number of shares outstanding of each of the ~~registrant~~issuer’s ~~common~~classes ~~stock~~of ~~outstanding~~common equity, as of ~~March~~the ~~31,~~latest ~~2016~~practicable ~~was 1,111,460~~date.

Class		Outstanding as of December 31, 2017
Common Stock, $0.005 par value		1,111,460 shares
Preferred Stock, $0.001 par value		0 shares

DOCUMENTS INCORPORATED BY REFERENCE

A description of "“Documents Incorporated by Reference"” is contained in Part IV, Item 15.

PROTECT PHARMACEUTICAL CORPORATION

TABLE OF CONTENTS

		Page
PART I.
PART I
	ITEM 1.	Business	3-4
Item 1.	Business	3
	ITEM 1A.	Risk Factors	4
Item 1A.	Risk Factors	7
	ITEM 1B.	Unresolved Staff Comments	5
Item 1B.	Unresolved Staff Comments	8
	ITEM 2.	Description of Properties	5
Item 2.	Description of Properties	8
	ITEM 3.	Legal Proceedings	5
Item 3.	Legal Proceedings	8
	ITEM 4.	Mine Safety Disclosures	5
Item 4.	Mine Safety Disclosures	8
PART II.
PART II
	ITEM 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	6-7
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer
	ITEM 6.	Selected Financial Data	7
	Purchases of Equity Securities	8
	ITEM 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	7-11
Item 6.	Selected Financial Data	10
	ITEM 7A.	Quantitative and Qualitative Disclosures About Market Risk	11
Item 7.	Management's Discussion and Analysis of Financial Condition and Results
	ITEM 8.	Financial Statements and Supplementary Data	11-22
	of Operations	10
	ITEM 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	23
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	13
	ITEM 9A.	Controls and Procedures	23-24
Item 8.	Financial Statements and Supplementary Data	13
	ITEM 9B.	Other Information	24
Item 9.	Changes in and Disagreements with Accountants on Accounting and
PART III.
	Financial Disclosure	24
	ITEM 10.	Directors, Executive Officers and Corporate Governance	25
Item 9A.	Controls and Procedures	24
	ITEM 11.	Executive Compensation	25
Item 9B	Other Information	25
	ITEM 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	25
PART III
	ITEM 13.	Certain Relationships and Related Transactions, and Director Independence	25
Item 10.	Directors, Executive Officers and Corporate Governance	25
	ITEM 14.	Principal Accounting Fees and Services	25-26
Item 11.	Executive Compensation	27
PART IV.
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related
	ITEM 15.	Exhibits, Financial Statement Schedules	27
	Stockholder Matters	28
	ITEM 16.	Form 10-K Summary	27
Item 13.	Certain Relationships and Related Transactions and Director Independence	28
		Signatures	28
Item 14.	Principal Accounting Fees and Services	29
PART IV
Item 15.	Exhibits, Financial Statement Schedules.	30
	Signatures	31

PART I

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K includes “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as well as historical information. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or industry results, to be materially different from anticipated results, performance or achievements expressed or implied by such forward-looking statements. When used in this Annual Report on Form 10-K, statements that are not statements of current or historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “plan,” “intend,” “may,” “will,” “expect,” “believe,” “could,” “anticipate,” “estimate,” or “continue” or similar expressions or other variations or comparable terminology are intended to identify such forward-looking statements, although some forward-looking statements are expressed differently. We remind readers that forward-looking statements are merely predictions and therefore inherently subject to uncertainties and other factors and involve known and unknown risks that could cause the actual results, performance, levels of activity or our achievements or industry results, to be materially different from any future results, performance levels of activity or our achievements or industry results expressed or implied by such forward-looking statements. Such forward looking statements appear in Item 1- “Business” and Item 7- “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as elsewhere in this Annual Report. Factors that could cause our actual results to differ materially from anticipated results expressed or implied by forward-looking statements include, among others:

Except as required by law, the Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Unless otherwise indicated or the context otherwise requires, all references in this Form 10-K to “we,” “us,” “our,” “our company,” “Protect ~~Pharmaceutical~~Pharmaceuticals Corporation” or the “Company” refer to Protect ~~Pharmaceutical~~Pharmaceuticals Corporation.

Item 1. Business.

History

~~Protect~~Catch-Up Filing: ~~Pharmaceutical~~This ~~Corporation~~10-K ~~was~~provides ~~originally~~business ~~incorporated~~information infor ~~the~~2017 ~~State~~not ofprovided ~~Idaho~~in onprior ~~August 5, 1987, under the name Interstate Mining and Development Properties, Inc~~filings. ~~The~~Earlier ~~Company~~history ~~initially~~was ~~staked~~provided in ~~certain gold placer mining claims, however~~ the ~~claims did not yield a sufficient amount of ore and the~~ Company’s ~~halted~~2016 ~~operations in approximately 1989~~10-K.

On2017-2018 Transactions: ~~August~~The 2,Company ~~1996,~~went ~~the~~through ~~Company~~several ~~changed~~changes ~~its~~of ~~name~~control toand ~~Interstate~~management ~~Development,~~in ~~Inc. Also~~2017 inand ~~August~~2018 ~~1996,~~before ~~two~~current ~~individuals,~~management was H.elected ~~Deworth~~to ~~Williams~~office and ~~Geoff~~purchased ~~Williams,~~control ~~acquired controlling interest~~ of the Company’s ~~outstanding~~in ~~common~~November ~~stock~~2018. ~~through~~Shareholder ~~the~~and ~~private~~Board ~~purchase~~ of ~~shares~~Directors ~~from~~action ~~the~~as ~~Company’s~~of ~~two~~January 30, ~~largest~~2019 ~~shareholders.~~affirmed ~~The~~and ~~Company~~ratified ~~then~~certain ~~engaged~~past inactions ~~the~~and ~~search~~disaffirmed ~~for~~ and ~~evaluation~~cancelled ofseveral ~~prospective~~actions, ~~business~~some ~~opportunities~~of ~~with~~which ~~the~~may ~~intent~~not tohave been ~~acquire~~fully ~~and/~~executed or ~~merge~~may ~~with~~not ~~one~~have orcome ~~more~~into ~~businesses~~final ~~opportunities~~legal effect. These items were reported on Form 8-K January 31, 2019, and were as follows:

~~On July 3, 2006, the Company’s stockholders approved the change of the corporation’s domicile from Idaho to Nevada~~A. Affirmed ~~On December 14, 2006, the change of domicile to Nevada was finalized by merging with~~ and into Interstate Acquisition, Inc. (incorporated in Nevada on June 15, 2006) for the sole purpose of changing corporate domicile. The Idaho entity was then dissolved and on December 15, 2006, we changed the name of the Nevada entity to Pro-Tect, Inc. and continued to explore possible business opportunities.Ratified:

~~On February 12~~June 30, ~~2010,~~2017 we- ~~entered~~Rescission ~~into~~& aRelease ~~Patent~~of ~~Acquisition~~Securities Purchase Agreement: ~~with~~Eight ~~Nectid,~~Dragons ~~Inc.,~~(EDRG) aagreed ~~privately~~to ~~held~~purchase ~~Princeton~~6,100,000 ~~New~~shares of ~~Jersey~~PRTT ~~based~~common ~~company,~~stock ~~whereby~~in weexchange ~~acquired~~for ~~from~~3,000,000 ~~Nectid~~EDRG ashares ~~portfolio~~with ofa ~~pending~~conversions ~~patent~~ration ~~applications~~of ~~relating~~EDRG to ~~three~~PRTT ~~drug~~of ~~delivery technologies~~$2.03 ~~Our primary purpose at that time was~~ to ~~develop~~$1.00. ~~drug~~EDRG ~~delivery technologies~~ and PRTT ~~solutions~~subsequently ~~through~~executed ~~innovative~~a ~~dosing~~Rescission ~~and/or~~& ~~delivery~~Mutual ~~that~~Release ~~would~~on ~~minimize~~ the ~~pharmaceutical~~same ~~dose~~day, ~~frequency~~June 30, ~~and~~2017, ~~side~~to ~~effects.~~cancel Inthe ~~connection~~transaction ~~with~~and vacate the ~~acquisition,~~associated weSecurities ~~changed~~Purchase ~~our~~Agreement. ~~corporate~~As ~~name~~a toresult, ~~Protect~~no ~~Pharmaceutical~~shares ~~Corporation~~were onissued ~~April~~or ~~23,~~exchanged ~~2010~~by either company.

4June 1, 2018 – Change of Officers and Board of Directors: Yvette Sanchez was appointed by the board of directors as President of the Company June 1, 2018.

~~In exchange for the acquired patent applications~~June 1, we2018 ~~issued~~– toConvertible ~~Nectid~~Loan: ~~5.0~~Convertible ~~million~~Promissory ~~shares~~Note offor ~~our common stock (pre-split) and agreed to issue an additional 2.0 million shares upon realizing financing of~~ $2.0 million. The acquisition agreement provided certain registration rights whereby the Company would use its best efforts to file with the SEC a registration statement under the Securities Act of 1933230,000 ~~which~~from ~~would~~J&Y ~~include~~Property ~~shares~~Preservation ~~issued to Nectid under the agreement~~LLC. ~~We did not realize the financing nor issued the additional 2 million shares and, accordingly, no registration statement was filed.~~

InJune 5, 2018 – SEC Form 14f Filing and Restructuring Agreement: Effective June ~~2010~~5, we2018, ~~filed~~J&Y Property Preservation LLC (the “Buyer”), a ~~Form~~Nevada LLC, entered into a Stock Purchase Agreement (the “Agreement”), dated June 1, 2018 with Start Capital LLC, a Florida LLC and Renewable Energy LLC (“StartRenewable”), a Florida LLC, the principal stockholders of PRTT, pursuant to which, among other things, StartRenewable agreed to sell to the Buyer, and the Buyer agreed to purchase from StartRenewable, a total of 10,215,000 shares ~~registration~~of ~~statement~~Common ~~under~~Stock owned of record and beneficially by StartRenewable (the ~~Securities~~“Purchased ~~Exchange~~Shares”). ~~Act~~The Purchased Shares represented approximately 70.4% of ~~1934~~the Company’s issued and outstanding shares of Common Stock as of the Record Date. In connection Aswith athe ~~result~~transactions contemplated by the Agreement, Yvette Sanchez removed the current directors by Unanimous Consent in Lieu of ~~filing~~a Shareholder Meeting and appointed herself to the ~~registration~~Company’s ~~statement~~Board of Directors. J&Y Property Preservation LLC shares were acquired equal to 18% ownership of the Buyer, webut ~~became~~the ~~obligated~~Company neglected to implement ~~file~~(i) ~~certain~~the ~~interim~~change ~~and~~of ~~periodic~~primary ~~reports~~operating entity nor (ii) the change of real estate business model, ~~including~~both anof ~~annual~~which ~~report~~were announced ~~containing~~in ~~audited~~a ~~financial~~June ~~statements~~5, 2018 Form 8-K.

In December 2010, we amended the acquisition agreement to provide that in the event the company sold outright any of the patents acquired from Nectid, without first undertaking any development of the patents, the proceeds from such sale would be divided, 60% to Nectid and 40% to the Protect.3

~~On January 31~~June 15, ~~2011,~~2018 we– ~~finalized~~Change ato ~~Patent~~Board ~~Purchase~~of ~~Agreement~~Directors: ~~with~~Yvette ~~Grünenthal~~Sanchez ~~GmbH,~~was appointed a ~~company~~member ~~organized~~of ~~under~~ the ~~laws~~Board of ~~Germany.~~Directors ~~Pursuant~~by to the ~~terms~~existing Board of ~~that~~Directors. ~~agreement,~~Ms. ~~Grünenthal~~Sanchez ~~purchased~~removed ~~all of~~ the ~~company’s~~following ~~rights,~~former ~~title~~members ~~and~~from ~~interest~~the inBoard ~~and~~of toDirectors ~~certain~~with ~~inventions~~their ~~described~~consent: inShedrick Daniels, ~~patents~~Stuart ~~and~~Sandweiss, ~~patent applications. The patents relate to Opioid Formulations~~ and ~~Methods~~Shimson ~~of treating acute and chronic pain~~Bandman.

~~In exchange for the patents~~June 28, ~~Grünenthal~~2018 ~~paid~~- ~~the~~Loan: ~~cash consideration of~~ $~~1.6 million. Pursuant to our agreement with Nectid~~20, ~~because the patents were sold outright without first undertaking any development of the patents, the proceeds were divided 60% to Nectid and 40% to Protect. Accordingly, the Company realized $640,~~000 from ~~the~~Precise ~~sale~~Property ~~and~~Preservation ~~the balance was paid~~ to ~~Nectid.~~Protect ~~We retained all other inventions, patents and technologies initially acquired from Nectid~~Pharmaceutical.

~~On January 24~~July 7, ~~2012,~~2018 ~~Ramesha~~- ~~Sesha~~8-K ~~tendered~~filed: ~~his~~Announced ~~resignation~~that as ~~an officer and director~~ of ~~the~~June ~~Company. He~~30, ~~was replaced on February 12~~2018, ~~2012 by Geoff Williams~~ as ~~chief~~consideration ~~executive~~for ~~officer,~~contractual ~~president~~obligations, ~~treasurer~~ and ~~director.~~shares of ~~Following~~our ~~Mr.~~common ~~Sesha’s~~stock ~~resignation,~~were ~~we continued~~ to ~~explore~~be ~~possible~~issued. ~~development~~Actual ~~and~~issuances ~~commercialization~~were ofdifferent ~~the differentiated products based on our remaining proprietary oral drug delivery technologies~~ and ~~patents~~not ~~acquired~~as ~~from~~then ~~Nectid. Subsequently~~proposed, ~~management~~but ~~concluded~~are ~~that~~reflected itin ~~would be difficult to continue with this plan without acquiring~~ the Company’s ~~necessary~~current ~~qualified~~record ~~scientific~~of ~~personnel.~~share ~~Accordingly~~issuances, wewhich ~~decided~~is tohereby ~~explore alternative business ventures~~validated.

~~On September 19~~July 7, ~~2014,~~2018 ~~the~~- ~~Company~~8-K ~~entered~~filed: ~~into~~Document aJuly ~~Claims Assignment Agreement with Blue Cap Development Corp.~~6, a2018: ~~private~~CEO ~~Nevada corporation (“Blue Cap”), to acquire certain mining~~ and~~/or~~ ~~mineral~~Board ~~claims~~members ~~and/or~~were ~~leases located in Sec. 6~~named, ~~T2S,~~but ~~R1W,~~all ~~New~~have ~~Mexico~~since ~~Principal Meridian, of Soccorro County New Mexico (the “Claims”)~~resigned.

~~In exchange for the Claims~~October 9, we2018 ~~issued 26.0 million (pre~~-~~split~~ asLoan: ~~described below) shares of authorized~~$3,100 ~~but~~from ~~previously~~Burton ~~unissued~~Steer ~~common stock. The amount of shares was negotiated between the parties~~ and ~~the~~Associates ~~26.0~~on ~~million~~October ~~shares represented approximately 36.~~9%, of2018; ~~the~~received ~~shares~~in ~~then~~two ~~outstanding~~installments ~~following the acquisition. Two principals~~ of ~~Blue Cap~~$2,100 ~~Edward~~on F.October 9, ~~Cowle~~2018 and ~~H. Deworth Williams~~$1,000 ~~are~~on ~~principal~~October ~~stockholders~~25, of2018; ~~Protect~~$3,000 ~~and~~repaid ~~owned~~as ~~approximately 31%~~ of ~~Protect’s~~December ~~common stock prior to the acquisition. Because of the related nature of the parties to the transaction~~31, ~~Protect endeavored to conduct an independent investigation of Blue Cap and the Claims and research the merits and value of acquiring the Claims~~2018.

~~Protect~~November 13, 2018 - SEC 8-K filing: The Board of Directors appointed Una Taylor as a member of the Company’s ~~past~~Board ~~President,~~of ~~Geoff Williams~~Directors, effective ~~oversaw~~at the ~~investigation~~close ~~and~~business ~~consulted~~as ~~with~~of ~~outside~~November ~~advisors~~12, 2018. ~~Geoff~~November ~~Williams~~12, is2018, ~~the~~Board ~~son~~of Directors issued 1,000,000 shares of preferred H.stock, ~~Deworth~~Series ~~Williams~~A, to Una J. ~~The~~Taylor, ~~Company~~each ~~researched~~share ~~information~~to ~~and~~have ~~documents~~1,000 ~~related~~votes. toYvette ~~the~~Sanchez ~~Blue~~resigned ~~Cap~~as ~~Claims~~an officer of Protect Pharmaceutical Corporation and ~~consulted~~of ~~with~~the ~~other~~Board ~~persons~~of ~~familiar~~Directors, ~~with~~effective ~~the~~November ~~properties~~13, 2018. Shares and ~~the~~expense ~~industry~~reimbursement were authorized for Ms. ~~Following~~ Taylor. Previous shares from the ~~review~~transactions ofnaming ~~all~~Yvette ~~available~~Sanchez ~~information,~~President itwere ~~was~~sold ~~determined~~or ~~that~~otherwise ~~the~~dealt ~~acquisition~~with ofin the reaffirmed ~~Claims~~November ~~presented~~transactions. aMs. ~~unique~~Taylor ~~opportunity~~was ~~for~~also ~~the~~appointed ~~company~~Chief Executive Officer (CEO) on November 13, 2018. ~~Management~~ ~~believes~~CEO ~~that~~employment agreement ~~the~~with ~~acquisition~~Una ~~was~~Taylor ~~accomplished~~on ~~for~~November a14, ~~fair~~2018; $250,000 ~~negotiated~~salary, ~~consideration~~$50,000 ~~and~~bonus, ~~the~~insurance ~~acquisition~~of is$1,983 inper ~~the~~month ~~best~~until ~~interest~~the end of the ~~our~~2019 ~~stockholders~~calendar year or until company offers benefits. This action was subsequently ratified by the Board of Directors.

~~Our~~December 10, ~~decision~~2018 to- ~~enter~~SEC ~~into~~8-k ~~the~~Filing: ~~Claims~~Document ~~Acquisition~~Date ~~Agreement~~November ~~was premised on the Board of Directors intention to diversify the Company’s future business. As a result of acquiring the Claims~~28, we2018 ~~are~~- ~~developing~~Wajed aSalem ~~plan~~named to ~~commence~~Board ~~an exploration program for the possibility~~ of ~~deposits~~Directors ofby ~~rare earth elements on~~ the ~~Claims. Rare~~existing ~~earth elements are essential for a diverse and expanding array of high-technology applications and for many current and emerging alternative energy technologies~~board, ~~such as electric vehicles, energy-efficient lighting,~~ and ~~wind~~the ~~power. Examples~~Company ofentered ~~products~~into ~~that~~contract ~~use~~with ~~rare earth elements are computer hard drives, smart phones, TV screens and wind turbines~~him. ~~Rare earth elements are also critical for a number of key defense systems such as lasers, radar, missile-guidance systems and other electronics.~~

~~Management~~December 17, ~~anticipates~~2018 ~~that~~- ~~the~~Loan: ~~Company~~$25,000 ~~will~~from ~~need~~Audra ~~to secure adequate funding to develop and implement an exploration program~~M. ~~There~~Hajj ~~can be no assurance that we will be able~~ to ~~secure~~Protect ~~the necessary funding to fulfill our goals, or that any future funding will be available on terms favorable to the Company, or at all~~Pharmaceutical.

~~Our 10 lode mining claims are located in Sec~~Misc. dates 6,- ~~T2S,~~Contracts: ~~R1W,~~Engagement ~~New~~or ~~Mexico~~replacement ~~Principal Meridian,~~ of ~~Soccorro~~attorneys ~~County~~or auditors, ~~New~~at ~~Mexico. The Claims are being held for~~ the ~~purpose~~CEO’s ~~of exploration for gold~~discretion, ~~silver~~with ~~and~~written ~~rare~~or ~~earth mineralization deposits and are located near existing exploration projects and we expect will be explored by~~ other contract ~~mining~~terms, ~~companies. Extensive~~again ~~exploration~~at ~~will be required before we can make a final evaluation as to~~ the ~~economic~~discretion ~~and legal feasibility~~ of ~~any~~CEO ~~potential~~Una ~~deposit~~J. ~~According to SEC Industry Guide No~~Taylor. 7, we are classified or considered an exploration stage mining company. This is defined as a company engaged in the search for mineral deposits or reserves of precious and base metal targets, which are not in either the development or production stage.

On September 9, 2016, effective September 9, 2016, Deworth Williams, the principal stockholder of the Company (“Williams”), entered into a Stock Purchase Agreement (the “Agreement”), as amended (the “Amended Agreement”), dated, August 30, 2016, with Taylor Group Holdings, LLC (the “Buyer”), a Florida Limited Liability Company, pursuant to which, among other things, Williams agreed to sell to the Buyer, and the Buyer agreed to purchase from Williams, a total of 937,063 shares of Common Stock owned of record and beneficially by Williams (the “Purchased Shares”)B. ~~The~~ Disaffirmed ~~Purchased Shares represented approximately 84.3% of the Company’s issued~~ and ~~outstanding shares of Common Stock as of the Record Date. In connection with the transactions contemplated by the Agreement~~Cancelled, ~~the~~Or ~~Board~~Never ~~appointed~~Came ~~Una~~Into ~~Taylor~~Legal ~~and Theodore Faison to fill vacancies on the Company’s Board of Directors.~~Effect:

~~On September 20~~June 5, ~~2016,~~2018 we- ~~announced~~Change ~~that~~of ~~Protect Pharmaceutical intended~~primary tooperating ~~acquire~~entity ~~DreamFU~~and ~~Ventures~~business ~~LLC~~model: aThe ~~Florida~~Company ~~LLC~~did innot ~~a transaction~~implement ~~that will result in~~ the ~~DreamFu~~change ~~entity~~of ~~becoming~~primary ~~the~~ operating entity inor ~~our~~real ~~public~~estate ~~company~~business ~~(“Merger”)~~model ~~and~~announced ~~that will also result~~ in ~~Protect Pharmaceutical acquiring~~a ~~100%~~June ~~of the issued and outstanding equity of DreamFu Ventures LLC. During the fourth quarter~~5, we2018 ~~abandoned~~Form ~~this transaction~~8-K.

~~We currently have limited capital and no revenues. Management anticipates that in the near term~~September 14, ~~ongoing~~2018 ~~expenses,~~- ~~including~~Press ~~the~~Release: ~~costs~~Company ~~associated~~Announces ~~with~~New ~~the~~Business ~~preparation~~Model; ~~and~~transaction ~~filing with the SEC of requisite reports, will be paid for by advances from stockholders or from the private sale of securities, either debt or equity~~cancelled. ~~However, there is no assurance that we will be able to realize such funds on terms favorable to us, or at all.~~

~~Our~~October 20, ~~principal~~2018 ~~offices~~- ~~are~~Merger/Acquisition: ~~currently~~Tobit ~~located~~Clicks atof 95Tobit ~~Merrick~~LLC; ~~Way,~~transaction ~~Third Floor, Coral Gables, Florida 33143~~cancelled.

~~and~~October 2, ~~our~~2018 ~~telephone~~- ~~number~~Press isRelease: ~~(954)~~Company ~~292-0033~~Joins Tobit Consortium; transaction cancelled.

~~Reverse~~November 27, ~~Stock~~2018 ~~Split~~- Private Placement: International Membership Data, LLC, $40 million to be invested by Company; transaction cancelled.

On November 4 28, ~~2014,~~2018 ~~Protect~~- ~~effected~~Merger/Acquisition: aTarget: ~~reverse~~The stock split of its 70,513,012 million issued and outstanding shares of common stock on a one (1) share for one thousand (1000) shares basis. As per the terms of the reverse stock split, any fractional share amount resulting from the split was automatically rounded up to the next higher whole share amount, with the provision that no individual stockholderWinner’s ~~holdings~~Circle ~~would~~Partners beLLC; ~~reduced~~transaction ~~below 100 shares~~cancelled. Accordingly, additional shares to restore each such affected stockholder’s holdings to 100 shares were issued. The par value of the common stock remains at $0.005 per share. All subsequent references to the number of shares will be on a post-split basis unless otherwise noted. As a result of the reverse stock split and the rounding up of odd lots to 100 shares, as of the date of this report we have issued and outstanding approximately 1,111,460 shares of common stock.

~~Each~~December 7, ~~share~~2018 ~~certificate representing shares of pre~~-~~split~~ ~~common~~Press ~~stock~~Release: isAES ~~deemed~~and toOnliFunds ~~represent~~Launch ~~one-thousandth~~OnliChain ~~(1/1000)~~focused ~~shares~~$250 ofmillion ~~post-split common stock~~Fund. ~~Certificates~~ ~~representing post-split common stock will be issued in due course as old share certificates are tendered for exchange or transfer to the~~ Company’s ~~transfer~~option ~~agent~~transaction cancelled.

~~Business~~Current and ~~Development~~Planned ~~Strategies~~Operations:

WePRTT is ~~reviewed~~an ~~the~~inactive ~~Company’s~~entity, ~~remaining~~reporting ~~patents~~as ~~and~~a ~~new~~shell ~~generation~~public ~~drug~~company. ~~delivery~~The ~~technologies~~company ~~acquired~~is inseeking ~~2010.~~outside ~~However~~investors, ~~without~~most ~~personnel~~probably ~~with~~though ~~the~~a ~~requisite~~private placement ~~scientific~~of ~~expertise~~company shares, ~~management~~and ~~feels it~~ will becommence ~~difficult~~active ~~to further develop the technologies. Accordingly, our primary~~ business ~~focus~~operations ~~has~~of ~~shifted~~whatever totype ~~the~~is ~~exploration~~appropriate offor ~~the~~investors ~~acquired properties~~ willing to ~~determine~~complete ~~whether~~an ~~there~~acceptable istransaction ~~commercial~~with ~~potential~~current management.

~~In order to facilitate an exploration program, we will need to raise adequate funds to complete initial exploration commitments and pay general business and operating expenses~~Item 1A. WeRisk ~~estimate that we will need up to $100,000 during the next twelve months to complete the initial phase of exploration and to commence an exploration program on our properties~~Factors. Management plans to explore a possible private placement of our securities and/or debt financing to raise the additional fund, although no definitive plan has been formulated and there can be no assurance that we will be able to realize the necessary funds.

IfPRTT has weless ~~are~~than ~~able~~300 toshareholders ~~complete our initial exploration programs~~ and ~~successfully~~has ~~identify~~assets athat ~~mineral~~make ~~deposit,~~it we will need substantial additional funds for drilling and engineering studies to determine whether any identified mineral deposit is commercially viable. If we are unable to raise additional funds for this work or secure a ~~strategic~~smaller ~~partner,~~reporting ~~we would be unable to proceed~~company, ~~even~~so ifno adisclosure ~~mineral deposit~~ is ~~discovered and is believed to be commercially viable~~provided.

Historically, we have incurred operating losses and we will not be able to exist indefinitely without securing additional operating funds. In the view of our independent auditors, we will require additional funds to maintain operations and these conditions raise substantial doubt about our ability to continue as a going concern.4

WeItem ~~anticipate that our immediate funding requirements will have to be satisfied by advances from officers, directors or stockholders~~1B. Unresolved WeStaff ~~will most likely accrue expenses when possible until a funding can be accomplished~~Comments. Management intends to hold expenses to a minimum and to obtain services on a contingency basis when possible. Further, we expect directors to defer any compensation until such time as we have sufficient funds. We have not yet entered into any arrangements or definitive agreements to use outside advisors or consultants or to raise any capital.

As it is most likely we will need to obtain outside financing, possibly the only method available would be the private sale of securities. It is unlikely that we could make a public sale of securities or be able to borrow any significant sum from either a commercial or private lender. There can be no assurance that we will be able to obtain necessary additional funding when and if needed, or that such funding, if available, can be obtained on acceptable terms.Not Applicable

5Item 2. Properties.

~~Current~~We do ~~Status~~not own any real property. We entered a rental agreement with J&Y Property Preservation on June 28, 2018, and currently occupy office space that serves as our principal place of business located at 4876 Cecile Avenue, Las Vegas, NV 89115.

~~The~~Item 3. ~~Company’s~~Legal ~~current business plan is to contemplate a possible future merger by the Company and either an affiliated entity or an as yet unknown other entity~~Proceedings.

~~The~~There are ~~Company’s~~no ~~common~~known ~~stock~~current isclaims ~~currently~~or ~~quoted~~legal onproceedings ~~the~~pending. QBThe ~~tier~~company is in process of ~~the~~completing ~~OTC~~current ~~Markets~~reporting ~~under~~and ~~the~~assuring FINRA ~~ticker~~and ~~symbol~~SEC ~~“PRTT”~~compliance with catch-up SEC reporting and answers to any staff questions.

~~The~~No recently ~~Company~~terminated ~~may~~legal ~~be referred to as a reporting shell corporation~~proceedings. Shell corporations have zero or nominal assets and typically no stated or contingent liabilities. Private companies wishing to become publicly trading may wish to merge with a shell (a reverse merger or reverse acquisition) whereby the shareholders of the private company become the majority of the shareholders of the combined company. The private company may purchase for cash all or a portion of the common shares of the shell corporation from its major stockholders. Typically, the Board and officers of the private company become the new Board and officers of the combined Company and often the name of the private company becomes the name of the combined entity.

~~The Company has very limited capital, and it is unlikely that the Company will be able to take advantage of more than one such business opportunity~~Item 4. ~~The~~ ~~Company~~Mine ~~intends~~Safety ~~to seek opportunities demonstrating the potential of long-term growth as opposed to short-term earnings~~Disclosures. However, at the present time, the Company has not identified any business opportunity that it plans to pursue, nor has the Company reached any agreement or definitive understanding with any person concerning an acquisition.

It is anticipated that the Company’s officers and directors will contact broker-dealers and other persons with whom they are acquainted who are involved with corporate finance matters to advise them of the Company’s existence and to determine if any companies or businesses that they represent have a general interest in considering a merger or acquisition with a blind pool or blank check or shell entityNot applicable. No assurance can be given that the Company will be successful in finding or acquiring a desirable business opportunity, given the limited funds that are expected to be available for acquisitions. Furthermore, no assurance can be given that any acquisition, which does occur, will be on terms that are favorable to the Company or its current stockholders.

The Company’s search will be directed toward small and medium-sized enterprises, which have a desire to become public corporations. In addition these enterprises may wish to satisfy, either currently or in the reasonably near future, the minimum tangible asset requirement in order to qualify shares for trading on NASDAQ or on an exchange such as the American Stock Exchange. The Company anticipates that the business opportunities presented to it will (I) either be in the process of formation, or be recently organized with limited operating history or a history of losses attributable to under-capitalization or other factors; (ii) experiencing financial or operating difficulties; (iii) be in need of funds to develop new products or services or to expand into a new market, or have plans for rapid expansion through acquisition of competing businesses; (iv) or other similar characteristics. The Company intends to concentrate its acquisition efforts on properties or businesses that it believes to be undervalued or that it believes may realize a substantial benefit from being publicly owned. Given the above factors, investors should expect that any acquisition candidate may have little or no operating history, or a history of losses or low profitability.5

The Company does not propose to restrict its search for investment opportunities to any particular geographical area or industry, and may, therefore, engage in essentially any business, to the extent of its limited resources. This include industries such as service, finance, natural resources, manufacturing, high technology, product development, medical, communications and others. The Company’s discretion in the selection of business opportunities is unrestricted, subject to the availability of such opportunities, economic conditions, and other factors.PART II

Any entity that has an interest in being acquired by, or merging into the Company, is expected to be an entity that desires to become a public company and establish a public trading market for its securitiesItem 5. InMarket connection with such a merger or acquisition, it is highly likely that an amount of stock constituting control of the Company would either be issued by the Company or be purchased from the current principal stockholders of the Company by the acquiring entity or its affiliates. If stock is purchased from the current principal stockholders, the transaction is likely to result in substantial gains to the current principal stockholders relative to their purchase price for ~~such stock. In the Company~~Registrant’s ~~judgment~~Common Equity, ~~none~~Related ofStockholder ~~the~~Matters ~~officers~~ and ~~directors~~Issuer ~~would~~Purchases ~~thereby become an underwriter within the meaning~~ of ~~the~~Equity ~~Section 2(11) of the~~ Securities ~~Act of 1933, as amended (the “Securities Act”) as long as the transaction is a private transaction rather than a public distribution of securities~~. The sale of a controlling interest by certain principal shareholders of the Company would occur at a time when minority stockholders are unable to sell their shares because of the lack of a public market for such shares.

~~Depending~~Our common ~~upon~~stock ~~the~~is ~~nature~~currently ofquoted ~~the~~on ~~transaction,~~ the ~~current~~OTC ~~officers~~Pink ~~and~~market ~~directors~~under of the ~~Company~~symbol ~~may~~PRTT. ~~resign~~There ~~their~~is ~~management~~a ~~and~~limited ~~board~~public ~~positions~~trading ~~with~~market ~~the~~for ~~Company~~our shares ~~in connection~~ with aonly ~~change~~sporadic oftrading. ~~control~~The orlast ~~acquisition~~reported oftrade aon ~~business~~December ~~opportunity. In~~13, ~~the~~2018, ~~event~~was of200,000 ~~such~~shares aat ~~resignation~~$1.70. Accordingly, because of the ~~Company’s~~limited ~~current~~trading ~~management~~information ~~would~~available, ~~thereafter~~we ~~have~~are nonot ~~control~~including ~~over~~a ~~the~~historical ~~conduct~~trading ~~of the Company’s business~~table.

ItAs of isthe ~~anticipated~~date ~~that~~hereof ~~business~~there ~~opportunities~~are ~~will~~approximately ~~come~~96 tostockholders ~~the~~of ~~Company’s~~record ~~attention~~of ~~from~~our ~~various~~common ~~sources~~stock, ~~including~~which ~~its~~figure ~~officers~~does ~~and~~not ~~directors,~~take ~~its~~into ~~other~~account those ~~stockholders,~~shareholders ~~professional~~whose ~~advisors~~certificates ~~such~~are asheld ~~attorneys~~in ~~and~~the ~~accountants,~~name ~~securities~~of broker-dealers, ~~venture capitalists, members of the financial community, and others who may present unsolicited proposals. The Company has no plan, understandings, agreements,~~ or ~~commitments~~other ~~with~~nominee ~~any individual for such person to act as a finder of opportunities for the Company~~accounts.

~~Investigation~~There were ~~and~~no ~~Selection~~sales of ~~Business~~unregistered ~~Opportunities~~securities ~~with~~of anthe ~~Affiliated~~Registrant ~~Entity~~sold orwithin ~~Other~~the ~~Potential~~last ~~Entities~~three years.

ToThere was ano ~~large~~repurchase ~~extent,~~made ~~a decision to participate~~ in a ~~specific~~month ~~business~~within ~~opportunity may be made upon management’s analysis of~~ the ~~quality~~last ofquarter ~~the other Company’s management and personnel, the anticipated acceptability~~ of new products or marketing concepts, the merit of technological changes, the perceived benefit the business opportunity will derive from becoming a publicly held entity, and numerous other factors which are difficult, if not impossible, to analyze through the application of any objective criteria2017. In many instances, it is anticipated that the historical operations of a specific business opportunity may not necessarily be indicative of the potential for the future because of a variety of factors, including, but not limited to, the possible need to expand substantially, shift marketing approaches, change product emphasis, change or substantially augment management, raise capital and the like.

ItRecent Issuances ~~is anticipated that the Company will not be able to diversify, but will essentially be limited to the acquisition~~ of one business opportunity because of the Company’s limited financing. This lack of diversification will not permit the Company to offset potential losses from one business opportunity against profits from another, and should be considered an adverse factor affecting any decision to purchase the Company’s securities.Securities

~~Certain~~There were ~~types~~no issuances of ~~business~~securities ~~acquisition~~in ~~transactions may be completed without any requirement that~~ the ~~Company~~fourth ~~first~~quarter ~~submit~~of ~~the transaction to the stockholders for their approval~~2017. In ~~the~~As ~~event~~of ~~the~~December ~~proposed~~31, ~~transaction is structured in such a fashion that stockholder approval is not required~~2017, ~~holders~~we ofhave ~~the~~outstanding ~~Company’s securities (other than principal stockholders holding~~ a ~~controlling~~total ~~interest) should not anticipate that they will be provided with financial statements or any other documentation prior to the completion~~ of ~~the~~1,111,460 shares ~~transaction. Other types~~ of ~~transactions~~common ~~require prior approval of the stockholders~~stock.

~~In the event a proposed business combination or business acquisition transaction is structured in such a fashion that prior stockholder approval is necessary~~18,839,918 shares ~~the~~of ~~Company~~common ~~will~~stock be(including ~~required to prepare a Proxy or Information Statement describing the proposed transaction~~3,000,000 ~~file~~of itrestricted ~~with~~shares) ~~the Securities~~ and ~~Exchange Commission for review and approval~~1,000,000 ~~and~~shares ~~mail a copy~~ of itpreferred tostock ~~all~~were ~~Company~~subsequently ~~stockholders prior to holding a stockholders meeting for purposes of voting on the proposal. Minority shareholders that do not vote~~ issued in ~~favor~~2018 ofas a proposed transaction will then have the right, in the event the transaction is approved by the required number of stockholders, to exercise statutory dissenter’s rights and elect to be paid the fair value of their shares.follows:

~~The~~September ~~analysis of business opportunities will be undertaken by or under the supervision of the Company’s officers and directors~~11, ~~none~~2018: ~~of whom are professional business analysts. Although there are no current plans to do so~~5,000,000 shares ~~Company management might hire an outside consultant to assist in the investigation and selection~~ of ~~business~~common ~~opportunities,~~stock ~~and might pay a finder’s fee. Since Company management has no current plans~~ to ~~use~~Una ~~any~~Taylor ~~outside consultants or advisors to assist in the investigation~~ and ~~selection of business opportunities~~10, ~~no policies have been adopted regarding use of such consultants or advisors~~393,000 ~~the~~shares ~~criteria to be used in selecting such consultants or advisors, the services to be provided, the term~~ of ~~service,~~common orstock ~~the total amount of fees that may be paid. However, because of the limited resources of the Company, it is likely that any such fee the Company agrees~~ to ~~pay~~Yvette ~~would be paid in stock and not in cash~~Sanchez.

~~The~~November 27, ~~Company~~2018: ~~is unable to predict when it may participate in a business opportunity. It expects~~3, ~~however~~000,000 ~~that~~restricted ~~the~~shares ~~analysis~~ of ~~specific~~common ~~proposals~~stock ~~and~~were ~~the~~subsequently ~~selection~~issued ofto aEight ~~business~~Dragons ~~opportunity may take several months or more~~Capital.

~~Prior to making a decision to participate in a business opportunity~~November 13, ~~the~~2018: ~~Company will generally request that it be provided with written materials regarding the business opportunity containing as much relevant information as possible~~1, ~~including~~000,000 ~~but~~shares ~~not limited to, such items as a description~~ of ~~products,~~preferred ~~services~~stock ~~and~~were ~~Company~~subsequently ~~history;~~issued management resumes; financial information; available projections, with related assumptions upon which they are based; an explanation of proprietary products and services; evidence of existing patents, trademarks, or service marks, or rights thereto; present and proposed forms of compensation to ~~management;~~Una a description of transactions between such Company and its affiliates during the relevant periods; a description of present and required facilities; an analysis of risks and competitive conditions; a financial plan of operation and estimated capital requirements; audited financial statements, or if they are not available, unaudited financial statements, together with reasonable assurance that audited financial statements would be able to be produced within a reasonable period of time not to exceed 60 days following completion of a merger or acquisition transaction; and the likeTaylor.

~~As part of the Company’s investigation~~December 11, ~~the~~2018: ~~Company’s executive officers and directors may meet personally with management and key personnel~~246,918 ~~may~~shares ~~visit~~of ~~and~~common ~~inspect~~stock ~~material~~were ~~facilities,~~subsequently ~~obtain~~issued ~~independent~~to ~~analysis~~Global orStartup ~~verification~~League ofas ~~certain~~payment ~~information~~for ~~provided,~~the ~~check~~value ~~references~~ of ~~management~~a ~~and~~convertible note ~~key~~per ~~personnel,~~a ~~and~~settlement ~~take~~agreement ~~other~~dated ~~reasonable~~September ~~investigative measures~~14, ~~to the extent of the Company’s limited financial resources and management expertise~~2018.

It is possible that the range of business opportunities that might be available for consideration by the Company could be limited by the impact of Securities and Exchange Commission regulations regarding purchase and sale of penny stocks. The regulations would affectDecember 13, ~~and~~2018: ~~possibly impair~~200,000 ~~any~~shares ~~market~~of ~~that~~common ~~might~~stock ~~develop~~were insubsequently ~~the~~issued ~~Company’s~~to ~~securities~~Sing ~~until such time as they qualify~~ for ~~listing~~Hope ~~on NASDAQ or on an exchange which would make them exempt from applicability of the penny stock regulations~~Inc.

~~Company management believes that various types~~ As of ~~potential~~December ~~merger~~31, or acquisition candidates might find a business combination with the Company to be attractive. These include acquisition candidates desiring to create a public market for their shares in order to enhance liquidity for current stockholders2018, ~~acquisition~~we ~~candidates which~~ have ~~long-term~~outstanding ~~plans~~a ~~for~~total ~~raising capital through public sale~~ of ~~securities and believe that the possible prior existence of a public market for their securities would be beneficial~~19,951,378 ~~and~~shares ~~acquisition candidates which plan to acquire additional assets through issuance~~ of ~~securities~~common ~~rather~~stock ~~than for cash,~~ and ~~believe that the possibility of development of a public market for their securities will be of assistance in that process. Acquisition candidates~~1, ~~who have a need for an immediate cash infusion~~000,000 ~~are~~shares ~~not~~of ~~likely~~preferred ~~to find a potential business combination with the Company to be an attractive alternative~~stock.

~~Form~~Penny Stock ofRule ~~Acquisition~~

ItThe ability isof ~~impossible~~individual stockholders to ~~predict~~trade ~~the~~their ~~manner~~shares in ~~which~~a ~~the~~particular ~~Company~~state may ~~participate in a business opportunity. Specific business opportunities will~~ be ~~reviewed~~subject asto ~~well~~various asrules ~~the respective needs~~ and ~~desires~~ regulations of ~~the~~that ~~Company~~state. ~~and~~A ~~the~~number ~~promoters~~ of ~~the~~states ~~opportunity~~require ~~and,~~that ~~upon~~an ~~the~~issuer’s ~~basis~~securities ofbe ~~the~~registered ~~review~~in ~~and~~their ~~the~~state ~~relative~~or ~~negotiating~~appropriately ~~strength~~exempted from ofregistration ~~the~~before ~~Company and such promoters,~~ the ~~legal~~securities ~~structure~~are orpermitted ~~method deemed by management~~ to betrade ~~suitable~~in ~~will~~that ~~be selected~~state. ~~Such~~ ~~structure may include~~Presently, ~~but~~we ishave ~~not~~no ~~limited~~plans to ~~leases,~~register ~~purchase~~our ~~and~~securities in ~~sale~~any ~~agreements,~~particular ~~licenses, joint ventures and other contractual arrangements~~state. ~~The~~ ~~Company~~Further, ~~may~~our ~~act~~common ~~directly~~stock ormost ~~indirectly~~likely ~~through~~will anbe ~~interest~~subject into athe ~~partnership,~~provisions ~~corporation or other form~~ of ~~organization. Implementing~~Section ~~such~~15(g) ~~structure~~and ~~may~~Rule ~~require~~15g-9 of the ~~merger~~Exchange Act, ~~consolidation~~commonly orreferred ~~reorganization~~to ofas the ~~Company~~“penny ~~with~~stock” ~~other~~rule. ~~corporations~~Section or15(g) ~~forms~~sets offorth ~~business~~certain ~~organization. In~~requirements for ~~addition,~~transactions ~~the~~in ~~present~~penny ~~management~~stocks and ~~stockholders~~Rule of15g-9(d)(1) incorporates the ~~Company~~definition ~~most likely will not have control~~ of apenny ~~majority of the voting~~ stock ofas ~~the~~that ~~Company~~used ~~following~~in aRule ~~merger~~3a51-1 ~~or reorganization transaction. As part~~ of ~~such a transaction,~~ the ~~Company’s~~Exchange ~~existing directors may resign and new directors may be appointed without any vote by stockholders~~Act.

It is ~~likely~~unlikely that ~~the~~our ~~Company~~securities will ~~acquire~~be ~~its~~listed ~~participation~~on inany anational ~~business~~or ~~opportunity~~regional ~~through~~exchange ~~the~~or ~~issuance~~The ofNASDAQ ~~Common~~ Stock orMarket ~~other~~in ~~securities of~~ the ~~Company~~foreseeable future. ~~Although~~ ~~the~~Therefore, ~~terms~~our ofshares ~~any~~most ~~such~~likely ~~transaction~~will ~~cannot~~ be ~~predicted,~~subject itto ~~should be noted that in certain circumstances~~ the ~~criteria~~provisions ~~for~~of ~~determining~~Section ~~whether~~15(g) orand ~~not~~Rule ~~an acquisition is a so~~15g-~~called~~9 ~~“B”~~of ~~tax free reorganization under~~ the ~~Internal~~Exchange ~~Revenue Code of 1986 as amended~~Act, commonly ~~depends~~referred ~~upon the issuance~~ to ~~the~~as ~~stockholders of~~ the ~~acquired~~“penny ~~Company~~stock” ~~of a controlling interest (i~~rule.~~e.,~~ ~~80%~~Section ~~or more~~15(g) ofsets ~~the~~forth ~~common~~certain ~~stock~~requirements offor ~~the~~broker ~~combined~~dealer entities immediately following the reorganization. If a transaction were structured to take advantage of these provisions rather than other tax free provisions provided under the Internal Revenue Code, the Company’s current stockholders would retain transactions in ~~the~~penny ~~aggregate~~stocks ~~20% or less of the total issued~~ and ~~outstanding~~Rule ~~shares. This~~15g-9(d)(1) ~~could~~incorporates ~~result in substantial additional dilution in~~ the ~~equity~~definition of ~~those~~penny ~~who~~stock ~~were~~as ~~stockholders~~that ofused ~~the~~in ~~Company~~Rule ~~prior~~3a51-1 ~~to such reorganization. Any such issuance~~ of ~~additional shares might also be done simultaneously with a sale or transfer of shares representing a controlling interest in~~ the ~~Company~~Exchange ~~by the current officers, directors and principal stockholders~~Act.

ItThe SEC isgenerally ~~anticipated~~defines ~~that~~a ~~any~~penny ~~new~~stock ~~securities~~to ~~issued~~be in any ~~reorganization~~equity ~~would~~security bethat ~~issued~~has ina ~~reliance~~market ~~upon~~price ~~one~~less orthan ~~more exemptions from registration under applicable federal and state securities laws to the extent that such exemptions are available~~$5. In00 ~~some~~per ~~circumstances~~share, ~~however,~~subject ~~as a negotiated element of the transaction, the Company may agree~~ to ~~register such securities either at the time the transaction is consummated or under~~ certain ~~conditions at specified times thereafter~~ exceptions. ~~The~~ ~~issuance~~Rule of3a51-1 ~~substantial~~provides ~~additional~~that ~~securities and their potential sale into~~ any ~~trading~~equity ~~market~~security ~~that~~is ~~might~~considered ~~develop~~to inbe ~~the Company’s securities may have~~ a ~~depressive~~penny ~~effect~~stock ~~upon~~unless ~~such~~that ~~market.~~security is:

~~The~~● ~~Company~~Registered ~~will~~and ~~participate~~traded inon a ~~business~~national ~~opportunity~~securities ~~only~~exchange ~~after~~meeting ~~the~~specified ~~negotiation~~criterion ~~and~~set ~~execution~~by ~~of a written agreement. Although~~ the ~~terms~~SEC; of● ~~such~~Authorized ~~agreement~~for ~~cannot~~quotation beon ~~predicted,~~The ~~generally~~NASDAQ ~~such~~Stock anMarket; ~~agreement~~● ~~would~~Issued ~~require~~by ~~specific~~a ~~representations~~registered ~~and~~investment ~~warranties~~company; by● ~~all~~Excluded offrom the ~~parties~~definition ~~thereto,~~on ~~specify~~the ~~certain~~basis ~~events~~ of ~~default,~~price ~~detail~~(at ~~the~~least ~~terms~~$5.00 ofper ~~closing~~share) ~~and~~or the ~~conditions~~issuer’s ~~which~~net ~~must~~tangible beassets; ~~satisfied~~or by● ~~each~~Exempted offrom the ~~parties~~definition ~~thereto~~by ~~prior to such closing, outline~~ the ~~manner of bearing costs if the transaction is not closed, set forth remedies upon default, and include miscellaneous other terms~~SEC.

As a general matter, the Company anticipates that it, and/or its principal stockholders will enter into a letter of intent with the management, principals or owners of a prospective business opportunity prior to signing a binding agreement. Such a letter of intent will set forth the terms of the proposed acquisition but will not bind any of the parties to consummate the transaction. Execution of a letter of intent will by no means indicate that consummation of an acquisition is probable. Neither the Company nor any of the other parties to the letter of intent will be bound to consummate the acquisition unless and until a definitive agreement is executed. Even after a definitive agreement is executed, it is possible that the acquisition would not be consummated should any party elect to exercise any right provided in the agreement to terminate it on specific grounds.6

ItBroker-dealers who issell ~~anticipated~~penny ~~that~~stocks ~~the~~to ~~investigation~~persons ~~of specific business opportunities and the negotiation, drafting and execution of relevant agreements, disclosure documents and~~ other ~~instruments~~than ~~will~~established ~~require~~customers ~~substantial management time~~ and ~~attention~~accredited ~~and~~investors ~~substantial~~are ~~costs~~subject ~~for~~to ~~accountants,~~additional ~~attorneys~~sales ~~and others~~practice requirements. If aAn ~~decision~~accredited investor is ~~made~~generally ~~not~~defined toas ~~participate in~~ a ~~specific~~person ~~business~~with ~~opportunity,~~assets ~~the costs incurred~~ in ~~the~~excess ~~related~~of ~~investigation~~$1,000,000 ~~would~~or ~~not~~annual beincome ~~recoverable. Moreover~~exceeding $200,000, ~~because many providers of goods and services require compensation at the time~~ or ~~soon after the goods and services are provided~~$300,000 ~~the~~together ~~inability~~with oftheir ~~the Company to pay until an indeterminate future time may make it impossible to produce goods and services~~spouse.

~~Investment~~For transactions ~~Company~~covered ~~Act~~by these rules, broker-dealers must make a special suitability determination for the purchase of such securities and ~~Other~~must ~~Regulation~~receive the purchaser’s written consent to the transaction prior to the purchase. Additionally, for any transaction involving a penny stock, unless exempt, the rules require the delivery, prior to the first transaction, of a risk disclosure document relating to the penny stock market. A broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative and current quotations for the securities. Finally, monthly statements must be sent to clients disclosing recent price information for the penny stocks held in the account and information on the limited market in penny stocks. Consequently, these rules may restrict the ability of broker-dealers to trade and/or maintain a market in our common stock and may affect the ability of stockholders to sell their shares.

~~The~~These requirements ~~Company~~ may ~~participate~~be inconsidered acumbersome ~~business opportunity~~ by ~~purchasing,~~broker-dealers ~~trading~~and orcould ~~selling~~impact the ~~securities~~willingness of ~~such~~a ~~business. The~~particular ~~Company~~broker-dealer ~~does not, however, intend~~ to make ~~engage~~a ~~primarily~~market in ~~such~~our ~~activities. Specifically~~shares, ~~the~~or ~~Company~~they ~~intends~~could toaffect ~~conduct~~the ~~its~~value ~~activities~~at sowhich asour toshares ~~avoid~~trade. ~~being~~Classification ~~classified as an investment Company under the Investment Company Act~~ of ~~1940 (~~the ~~Investment~~shares ~~Act),~~as ~~and~~penny ~~therefore~~stocks increases ~~to avoid application of~~ the ~~costly~~risk ~~and restrictive registration and other provisions~~ of ~~the~~an ~~Investment~~investment ~~Act,~~in ~~and~~our ~~the regulations promulgated thereunder~~shares.

~~The~~Rule 144 Company’s plan of business may involve changes in its capital structure, management, control and business, especially if it consummates the reorganization as discussed above. Each of these areas is regulated by the Investment Act, in order to protect purchasers of investment Company securities. Since the Company will not register as an investment Company, stockholders will not be afforded these protections.

~~Competition~~Rule 144 is the common means for a stockholder to resell restricted securities and for an affiliate to sell securities, either restricted or non-restricted (control) shares. Rule 144 was amended by the SEC, effective February 15, 2008.

~~The~~Under the ~~Company~~amended ~~expects~~Rule ~~to encounter substantial competition in its efforts to locate attractive business combination opportunities. The competition may in part come from business development companies~~144, ~~venture~~an ~~capital~~affiliate ~~partnerships and corporations, small investment companies, brokerage firms, and the like. Some~~ of ~~these types of organizations are likely to be in~~ a ~~better~~company ~~position~~filing ~~than~~reports under the ~~Company~~Exchange toAct ~~obtain~~who ~~access~~has toheld ~~attractive~~their ~~business~~shares ~~acquisition~~for ~~candidates~~more ~~either because they have greater experience, resources and managerial capabilities~~ than six ~~the Company~~months, ~~because~~may ~~they~~sell ~~are~~in ~~able~~any tothree-month ~~offer~~period ~~immediate~~an ~~access~~amount ~~to limited amounts~~ of ~~cash,~~shares orthat ~~for~~does anot ~~variety~~exceed ofthe ~~other~~greater ~~reasons. The Company also will experience competition from other public companies with similar business purposes, some~~ of ~~which may also have funds available for use by an acquisition candidate.~~:

Employees

	●	The average weekly trading volume in the common stock, as reported through the automated quotation system of a registered securities association, during the four calendar weeks preceding such sale, or
	●	1% of the shares then outstanding.

~~The~~Sales by ~~Company~~affiliates ~~currently~~under ~~has~~Rule no144 ~~employees. Management~~are ofalso ~~the~~subject ~~Company expects~~ to ~~use~~certain ~~consultants,~~requirements ~~attorneys and accountants~~ as ~~necessary, and does not anticipate a need~~ to ~~engage~~the ~~any~~manner ~~full-time~~of ~~employees~~sale, sofiling ~~long~~appropriate asnotice ~~it is seeking~~ and the ~~evaluating business opportunities. The need for employees and their~~ availability ~~will~~of becurrent ~~addressed~~public ininformation ~~connection~~about ~~with~~ the ~~decision whether or not to acquire or participate in specific business opportunities~~issuer.

~~Facilities~~A non-affiliate stockholder of a reporting company who has held their shares for more than six months, may make unlimited resales under Rule 144, provided only that the issuer has available current public information about itself. After a one-year holding period, a non-affiliate may make unlimited sales with no other requirements or limitations.

~~Our~~An important ~~principal~~exception ~~place~~to ofthe ~~business~~above isdescribed ~~located~~availability inof the ~~business~~amended ~~office~~Rule of144 ~~our~~is ~~President,~~that ~~Una~~Rule ~~Taylor,~~144 atis 95not ~~Merrick~~available ~~Way,~~for ~~Third~~either ~~Floor,~~a reporting ~~Coral~~or ~~Gables,~~non-reporting ~~Florida~~shell ~~33143.~~company, ~~Management~~unless ~~believes that~~ the ~~current facilities are adequate for the immediate future.~~company:

~~Industry~~● ~~Segments~~Has ceased to be a shell company; ● Is subject to the Exchange Act reporting obligations; ● Has filed all required Exchange Act reports during the preceding twelve months; and ● At least one year has elapsed from the time the company filed with the SEC current Form 10 type information reflecting its status as an entity that is not a shell company.

NoDividends Policy information is presented regarding industry segments. We are presently an exploration stage company engaged in the mineral exploration business and considered an exploration stage mining company. Reference is made to the statements of income included in this Form 10-K for a report of our operating history for the past two fiscal years.

6We have never declared cash dividends on our common stock, nor do we anticipate paying any dividends on our common stock in the foreseeable future.

Item 1A 6. ~~Risk~~Selected ~~Factors~~Financial Data.

~~This~~A registrant ~~item~~that qualifies as a smaller reporting company, like this Company, as defined by § 229.10(f)(1), is not required to ~~for~~provide athe ~~smaller~~information ~~reporting~~required ~~company~~by this Item.

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

~~Item~~The following 1Bdiscussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and notes thereto appearing elsewhere in this report.

~~Unresolved~~PRTT is ~~Staff~~an ~~Comments~~inactive entity, with no current revenues, reporting as a shell public company. The company is seeking outside investors, most likely though a private placement of company shares, and will commence active business operations of whatever type is appropriate for investors willing to complete an acceptable transaction with current management. We do not expect to realize revenues until we have completed a successful transaction without outside investors. In the near term, ongoing expenses, including the costs associated with the preparation and filing reports with the SEC, will be paid for by advances from stockholders and/or directors, or possibly from the private sale of securities, either debt or equity. However, there is no assurance that we will be able to realize such funds on terms favorable to us, or at all.

~~This item is not required for a smaller reporting company.~~7

~~Item~~Significant Accounting ~~2. Description of Property.~~Policies

~~We do not own any real property. We currently occupy office space that serves as our principal place of business located at 95 Merrick Way, Third Floor, Coral Gables, Florida 33143 at no charge.~~Accounting Method

~~Item~~These financial 3statements and related notes are presented in accordance with accounting principles generally accepted in the United States. ~~Legal~~The ~~Proceedings~~Company’s fiscal year-end is December 31.

~~There are no material pending legal proceedings to which the Company or any subsidiary is a party, or to which any property is subject and, to the best~~ Use of ~~our knowledge, no such action against us is contemplated or threatened.~~Estimates

~~Item~~The preparation 4of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

~~Mine~~Cash and ~~Safety~~Cash ~~Disclosures.~~Equivalents

~~Not~~The Company ~~applicable~~considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. As of December 31, 2017, and 2016 the Company had $0 and $0 of cash and cash equivalents, respectively.

~~PART II~~Revenue Recognition

~~Item~~The Company 5will recognize revenue from the performance of its services and/or sale of its products in accordance with ASC 605 “Revenue Recognition. Revenue will be recognized only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is provided, product is delivered, and collectability is assured.

~~Market~~Revenue from ~~for~~Contracts ~~Registrant’s~~with ~~Common Equity, Related Stockholder Matters and Issuer~~Customers

~~Purchases~~The Company applies Accounting Standards Update No. 2014-09 which was amended in August 2015 by Update No 2015-14: Revenue from Contracts with Customers. The standard outlines a five-step model for revenue recognition with the core principle being that a company should recognize revenue when it transfers control of ~~Equity~~goods ~~Securities~~or services to customers at an amount that reflects the consideration to which it expects to be entitled in exchange for those goods or services. This new guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. The Company adopted this standard on April 1, 2017 and has chosen to apply the standard using modified retrospective approach. Under the modified approach, financial statements are prepared for the year of adoption using the new standard, but prior periods presented will not be adjusted. The Company also determined that a cumulative catch-up adjustment to the opening balance of retained earnings was not necessary due to a lack of revenue in 2017.

Our common stock is currently quoted on the OTC Pink market under the symbol PRTT. There is a limited public trading market for our shares with only sporadic trading. The last reported trade on January 4, 2017, was 100 shares at $0.85. Accordingly, because of the limited trading information available, we are not including a historical trading table.Advertising Costs

AsThe Company offollows the ~~date~~policy ~~hereof~~of ~~there~~expensing ~~are~~advertising ~~approximately~~costs 82during ~~stockholders~~the ofperiod ~~record~~in ~~of our common stock,~~ which ~~figure~~they ~~does~~are ~~not~~incurred. ~~take~~The ~~into~~Company ~~account~~incurred ~~those~~no advertising ~~shareholders~~costs ~~whose~~during ~~certificates are held in~~ the ~~name~~years ofended ~~broker-dealers~~December or31, ~~other~~2017 ~~nominee~~and ~~accounts.~~2016, respectively.

Secondary trading of our shares may be subject to certain state imposed restrictions. Except for quotations on the OTC Pink, we have no immediate plans, proposals, arrangements or understandings with any person concerning the development of a trading market in any of our securities. The ability of individual stockholders to trade their shares in a particular state may be subject to various rules and regulations of that state. A number of states require that an issuer's securities be registered in their state or appropriately exempted from registration before the securities are permitted to trade in that state. Presently, we have no plans to register our securities in any particular state.Stock-based Compensation

~~Recent~~The Company ~~Issuances~~adopted ASC 718 effective January 1, 2006 using the modified prospective method. Under this transition method, stock compensation expense includes compensation expense for all share-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ~~Securities~~ASC 718. During the years ending December 31, 2017 and 2016, the Company issued $0 and $0, respectively, in share-based payments for services.

~~There~~Provision for ~~have no issuances of securities in the fourth quarter. As of the date of this report, we have outstanding a total of 1,111,460 shares of common stock.~~Taxes

~~Penny~~The Company ~~Stock~~applies ~~Rule~~ASC 740, which requires the asset and liability method of accounting for income taxes. The asset and liability method requires that the current or deferred tax consequences of all events recognized in the financial statements are measured by applying the provisions of enacted tax laws to determine the amount of taxes payable or refundable currently or in future years. Deferred tax assets are reviewed for recoverability and the Company records a valuation allowance to reduce its deferred tax assets when it is more likely than not that all or some portion of the deferred tax assets will not be recovered.

The ability of individual stockholders to trade their shares in a particular state may be subject to various rules and regulations of that state. A number of states require that an issuer's securities be registered in their state or appropriately exempted from registration before the securities are permitted to trade in that state. Presently, we have no plans to register our securities in any particular state. Further, our common stock most likely will be subject to the provisions of Section 15(g) and Rule 15g-9 of the Exchange Act, commonly referred to as the "penny stock" rule. Section 15(g) sets forth certain requirements for transactions in penny stocks and Rule 15g-9(d)(1) incorporates the definition of penny stock as that used in Rule 3a51-1 of the Exchange Act.8

It is unlikely that our securities will be listed on any national or regional exchange or The NASDAQ Stock Market in the foreseeable future. Therefore our shares most likely will be subject to the provisions of Section 15(g) and Rule 15g-9 of the Exchange Act, commonly referred to as the "penny stock" rule. Section 15(g) sets forth certain requirements for broker-dealer transactions in penny stocks and Rule 15g-9(d)(1) incorporates the definition of penny stock as that used in Rule 3a51-1 of the Exchange Act.Going Concern

The Company ~~SEC~~applies ~~generally~~Accounting ~~defines~~Standards aUpdate ~~penny~~2014-15, ~~stock~~“Presentation toof beFinancial ~~any~~Statements ~~equity~~– ~~security~~Going ~~that~~Concern ~~has~~(subtopic 205-40): aDisclosure ~~market~~of ~~price~~Uncertainties ~~less~~about ~~than~~an ~~$5.00~~Entity’s ~~per~~Ability ~~share,~~to ~~subject~~Continue toas ~~certain~~a ~~exceptions~~Going Concern.” ~~Rule~~The ~~3a51-1~~standard provides guidance ~~that~~about ~~any~~management’s ~~equity~~responsibility ~~security~~to evaluate whether there is ~~considered~~substantial doubt about the organization’s ability to becontinue as a ~~penny~~going ~~stock~~concern. ~~unless~~The ~~that~~amendments ~~security~~in ~~is:~~this update apply to all companies. They become effective in the annual period ending after December 15, 2016, with early application permitted. The Company adopted this standard on December 15, 2016.

●Basic Loss per Common Share

~~registered~~Basic loss ~~and~~per ~~traded~~share onis acalculated ~~national~~by ~~securities~~dividing ~~exchange~~the ~~meeting~~Company’s ~~specified~~net ~~criteria~~loss ~~set~~applicable to common shareholders by the ~~SEC;~~weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There was a convertible note in default as of December 31, 2017 that was subsequently converted into 246,918 shares of common stock on December 11, 2018.

●Convertible notes with fixed rate conversion options

~~authorized~~The Company ~~for~~may ~~quotation~~enter oninto convertible notes, some of which contain, predominantly, fixed rate conversion features, whereby the outstanding principal and accrued interest may be converted by the holder, into common shares at a fixed discount to the market price of the common stock at the time of conversion. This results in a fair value of the convertible note being equal to a fixed monetary amount. The ~~NASDAQ~~Company ~~Stock~~records ~~Market;~~the convertible note liability at its fixed monetary amount by measuring and recording a discount, as applicable, on the Note date with a charge of interest expense in accordance with ASC 480 – “Distinguishing Liabilities from Equity.”

● Convertible debt

In July 2017, the FASB issued byAccounting Standards Update No. 2017-11 Earnings Per Share (Topic 260) Distinguishing Liabilities from Equity (Topic 480) Derivatives and Hedging (Topic 8115) (“ASU 2017-11”), which changes the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a ~~registered~~down ~~investment~~round ~~company;~~feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. ASU 2017-11 also clarifies existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, ASU 2017-11 requires entities to present earnings per share (EPS) in accordance with ASC Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. For the Company, ASU 2017-11 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, including adoption in an interim period. The Company adopted this standard on July 1, 2017 and applied it retroactively to the Company’s financial reporting starting on April 1, 2017.

●Recent Accounting Pronouncements

~~excluded~~Management has ~~from~~considered ~~the~~all ~~definition~~recent onaccounting pronouncements issued since the ~~basis~~last audit of ~~price~~the ~~(at~~Company’s ~~least~~financial $5statements.00 ~~per~~The Company’s ~~share)~~management orbelieves ~~the~~that ~~issuer's~~these ~~net~~recent ~~tangible~~pronouncements ~~assets;~~will ornot have a material effect on the Company’s financial statements

8Forward-Looking and Cautionary Statements

●Unless otherwise indicated, references in this Annual Report on Form 10-K to “we,” “us,” and “our” are to the Company, unless the context requires otherwise. The following discussion and analysis by our management of our financial condition and results of operations should be read in conjunction with our unaudited condensed interim financial statements and the accompanying related notes included in this quarterly report and our audited financial statements and related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2016 filed with the Securities and Exchange Commission.

~~exempted from the definition by the SEC.~~9

~~Broker-dealers~~Cautionary Statement ~~who~~Regarding ~~sell~~Forward-Looking penny stocks to persons other than established customers and accredited investors are subject to additional sales practice requirements. An accredited investor is generally defined as a person with assets in excess of $1,000,000 or annual income exceeding $200,000, or $300,000 together with their spouse.Statements

~~For~~This report ~~transactions~~may ~~covered~~contain ~~by these rules, broker~~forward-~~dealers~~looking ~~must~~statements ~~make~~within ~~a special suitability determination for~~ the ~~purchase~~meaning of ~~such~~Section ~~securities~~27A ~~and~~of ~~must receive~~ the ~~purchaser's~~Securities ~~written~~Act ~~consent~~and toSection ~~the~~21E ~~transaction~~of ~~prior to~~ the ~~purchase.~~Securities Exchange ~~Additionally~~Act, ~~for~~and ~~any~~we ~~transaction~~intend ~~involving~~that asuch ~~penny~~forward-looking ~~stock,~~statements ~~unless~~be ~~exempt,~~subject to the ~~rules~~safe ~~require~~harbors ~~the~~created ~~delivery,~~thereby. ~~prior~~These toforward-looking statements ~~the~~are ~~first~~based ~~transaction,~~on ofour amanagement’s ~~risk~~beliefs ~~disclosure~~and ~~document~~assumptions ~~relating~~and toon ~~the~~information ~~penny~~currently ~~stock~~available ~~market~~to our management. Any Asuch ~~broker~~forward-~~dealer~~looking ~~also~~statements ~~must~~would ~~disclose~~be ~~the~~contained ~~commissions~~principally ~~payable~~in to“Management’s ~~both~~Discussion ~~the broker-dealer~~ and ~~the~~Analysis ~~registered~~of ~~representative~~Financial Condition and ~~current~~Results ~~quotations~~of ~~for~~Operations” ~~the~~and ~~securities~~“Risk Factors.” ~~Finally,~~Forward-looking ~~monthly~~ statements ~~must~~include beinformation ~~sent~~concerning our topossible ~~clients~~or ~~disclosing~~assumed ~~recent~~future ~~price~~results ~~information~~of ~~for~~operations, ~~the~~business ~~penny~~strategies, ~~stocks~~financing ~~held~~plans, incompetitive ~~the~~position, ~~account~~industry ~~and~~environment, potential ~~information~~growth onopportunities and the ~~limited~~effects ~~market~~of inregulation. ~~penny~~Forward-looking ~~stocks.~~statements ~~Consequently,~~include ~~these~~all ~~rules~~statements ~~may~~that ~~restrict~~are ~~the~~not ~~ability~~historical facts ofand ~~broker-dealers~~can tobe ~~trade~~identified ~~and/or~~by ~~maintain~~terms asuch ~~market~~as in“anticipates,” ~~our~~“believes,” ~~common~~“could,” ~~stock~~“estimates,” “expects,” ~~and~~“hopes,” “intends,” “may,” ~~affect~~“plans,” ~~the~~“potential,” “predicts,” ~~ability~~“projects,” of“should,” ~~stockholders~~“will,” to“would” ~~sell~~or ~~their~~similar ~~shares~~expressions.

~~These~~This report ~~requirements~~ may becontain ~~considered~~forward-looking ~~cumbersome~~statements bywithin ~~broker-dealers~~the ~~and~~meaning ~~could~~of ~~impact~~Section 27A of the ~~willingness~~Securities Act and Section 21E of athe ~~particular~~Securities Exchange ~~broker~~Act, and we intend that such forward-~~dealer~~looking statements be subject to ~~make~~the asafe ~~market~~harbors increated thereby. These forward-looking statements are based on our ~~shares,~~management’s orbeliefs ~~they~~and ~~could~~assumptions ~~affect~~and ~~the~~on ~~value~~information atcurrently ~~which~~available to our ~~shares~~management. Any ~~trade~~such forward-looking statements would be contained principally in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors.” ~~Classification~~Forward-looking statements include information concerning our possible or assumed future results of ~~the~~operations, ~~shares~~business asstrategies, ~~penny~~financing ~~stocks~~plans, ~~increases~~competitive position, industry environment, potential growth opportunities and the ~~risk~~effects of anregulation. ~~investment~~Forward-looking instatements ~~our~~include ~~shares~~all statements that are not historical facts and can be identified by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “hopes,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” or similar expressions.

~~Rule~~Forward-looking statements ~~144~~involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We discuss many of these risks in greater detail in “Risk Factors.” Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this report. You should read this report and the documents that we reference in this report and have filed as exhibits to the report completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

~~Rule~~Additional information ~~144~~concerning isthese ~~the~~and ~~common~~other ~~means~~risks ~~for~~and auncertainties ~~stockholder~~is tocontained ~~resell~~in ~~restricted~~our ~~securities~~filings ~~and~~with ~~for~~the anSecurities ~~affiliate~~and toExchange ~~sell securities~~Commission, including ~~either~~the ~~restricted~~section orentitled ~~non-restricted~~“Risk ~~(control)~~Factors” ~~shares.~~in ~~Rule~~our ~~144~~Annual ~~was~~Report ~~amended~~on byForm 10-K for the ~~SEC,~~year ~~effective~~ended ~~February~~December 1531, ~~2008~~2016.

~~Under~~Unless otherwise ~~the~~indicated ~~amended~~or ~~Rule 144, an affiliate of a company filing reports under~~ the ~~Exchange~~context ~~Act~~otherwise ~~who has held their shares for more than six months~~requires, ~~may~~all ~~sell~~references in ~~any~~this ~~three~~Form 10-~~month~~Q ~~period~~to an“we,” ~~amount~~“us,” “our,” of“our ~~shares~~company,” ~~that~~“Protect” ~~does~~refer ~~not~~to ~~exceed~~Protect ~~the~~Pharmaceutical ~~greater of:~~Corporation.

●Our Ability to Continue as a Going Concern

~~the~~Our independent ~~average~~registered ~~weekly~~public ~~trading~~accounting ~~volume~~firm has issued its report dated February 15, 2019, in connection with the ~~common~~audit of ~~stock,~~our annual financial statements as ~~reported~~of ~~through~~December ~~the~~31, ~~automated~~2017, ~~quotation~~that ~~system~~includes an explanatory paragraph describing the existence of conditions that raise substantial doubt about our ability to continue as a ~~registered~~going ~~securities~~concern ~~association,~~and ~~during~~Note 2 to the ~~four~~audited ~~calendar~~financial ~~weeks~~statements for ~~preceding~~the ~~such~~period ~~sale~~ended December 31, or2017 also describes the existence of conditions that raise substantial doubt about our ability to continue as a going concern.

●Results of Operations

1%For the ofYear ~~the~~Ended ~~shares~~December ~~then~~31, ~~outstanding.~~2017 and 2016

~~Sales~~We did bynot ~~affiliates~~realize ~~under~~revenues ~~Rule~~for ~~144~~the ~~are~~year ~~also~~ended ~~subject~~December to31, ~~certain~~2017 ~~requirements~~and as2016. toFor the ~~manner~~year ended December 31, 2017, the Company had operating expenses of ~~sale~~$115,400, ~~filing~~consisting ~~appropriate~~of ~~notice~~professional fees of $115,200 and ~~the~~general ~~availability~~& administrative expenses of ~~current~~$200. The ~~public~~increase ~~information~~in ~~about~~professional fees in the ~~issuer~~year ended December 31, 2017 is attributable to a contract with Trident for professional services. Interest expense for the year ended December 31, 2017 was $7,211, with the entire amount related to a convertible note with Trident.

ATotal operating ~~non-affiliate~~expenses ~~stockholder~~for ofthe ayear ~~reporting~~ended ~~company~~December ~~who~~31, ~~has~~2016, ~~held~~were ~~their~~$41,707, ~~shares~~consisting ~~for~~of ~~more than six months~~$37,225 ~~may~~in ~~make~~professional ~~unlimited~~fees ~~resales~~and ~~under~~$4,150 ~~Rule~~in executive ~~144~~compensation, ~~provided only~~ ~~that~~and ~~the~~$332 ~~issuer~~in ~~has~~general ~~available~~and ~~current~~administrative ~~public information about itself~~expenses. ~~After~~The aCompany ~~one-year~~did ~~holding~~not ~~period,~~have aany ~~non-affiliate~~interest ~~may~~expense ~~make~~in ~~unlimited sales with no other requirements or limitations~~2016.

AnThe net ~~important~~loss ~~exception~~for to the ~~above~~year ~~described~~ended ~~availability~~December of31, ~~the~~2017 ~~amended~~was ~~Rule~~$122,611 ~~144~~(-$0.11 isper ~~that~~share; ~~Rule~~-$0.10 ~~144~~diluted isloss ~~not~~per ~~available~~share, ~~for~~including ~~either~~246,918 shares attributable to convertible note), compared to a ~~reporting~~net orloss ~~non~~of $41,707 (-~~reporting~~$0.04 ~~shell~~per ~~company,~~share) ~~unless~~for the ~~company:~~year ended 2016.

●Liquidity and Capital Resources

~~has~~Total assets ~~ceased~~were to$0 beas aof ~~shell~~December ~~company;~~31, 2017 and $0 as of December 31, 2016. Total liabilities as of December 31, 2017 were $143,441, consisting of $101,000 in notes payable, $950 in accounts payable, $35,280 in related-party payables, and $6,211 in interest payable. At December 31, 2016, total liabilities were $20,830.

●10

Because we currently have limited revenues and cash, for the immediate future we believe we will have to rely on potential advances from stockholders to continue to implement our business activities. There is ~~subject~~no assurance that our stockholders will continue indefinitely to provide additional funds or pay our expenses. It is likely the ~~Exchange~~only ~~Act~~other ~~reporting~~source ~~obligations;~~of funding future operations will be through the private sale of our securities, either equity or debt.

●As of December 31, 2017, we had stockholders’ deficit of $143,441 compared to stockholders’ deficit of $20,830 as of December 31, 2016.

~~has~~Plan of ~~filed all required Exchange Act reports during the preceding twelve months; and~~Operation

●Our current business plan is to contemplate a possible a future business model change by the Company to generate adequate revenue to sustain operations and reduce dependency on shareholder funds. The Company also continues to explore acquisition of or acquisition by either an affiliated entity or an as yet unknown other entity.

atOur common ~~least~~stock ~~one~~is ~~year~~currently ~~has~~quoted ~~elapsed~~on ~~from~~ the ~~time~~QB ~~the~~tier ~~company~~of ~~filed with~~ the ~~SEC~~OTC ~~current~~Markets ~~Form~~under 10the ~~type~~ticker ~~information~~symbol ~~reflecting its status as an entity that is not a shell company~~“PRTT”.

9It is anticipated that business opportunities will come to our attention from various sources, including its officers and directors, its other stockholders, professional advisors such as attorneys and accountants, securities broker-dealers, venture capitalists, members of the financial community, and others who may present unsolicited proposals. We have no plan, understandings, agreements, or commitments with any individual for such person to act as a finder of opportunities for our company.

Because we currently have no cash, it may be necessary for officers, directors or stockholders to advance funds and we ~~were~~will ~~considered~~most likely accrue expenses until a ~~shell~~funding ~~company~~can ~~prior~~be accomplished. Management intends to ~~our~~hold ~~acquisition~~expenses ofto ~~patent~~a ~~applications,~~minimum inand ~~February~~to ~~2010,~~obtain ~~Rule~~services ~~144~~on a ~~was~~contingency ~~not~~basis ~~available~~when possible. Further, we expect directors to ~~our~~defer ~~stockholders~~any compensation until ~~one~~such ~~year~~time ~~after~~as ~~the~~we ~~filing~~have sufficient funds. We have not yet entered into any arrangements or ~~our~~definitive ~~registration~~agreements ~~statement~~to onuse ~~Form~~outside 10advisors inor ~~June~~consultants ~~2010.~~or to raise any capital.

We are ~~cannot~~currently ~~predict~~exploring ~~the~~possible ~~effect~~funding ~~any~~sources, ~~future~~but ~~sales~~we ~~under~~have ~~Rule~~not ~~144~~entered ~~may~~into ~~have~~any onarrangements ~~the~~or ~~market~~agreements ~~price~~for funding as of this ~~our~~time. ~~common~~If ~~stock~~we are unable to raise the necessary funding, ~~but~~our ~~such~~expansion ~~sales~~plans ~~may~~will ~~have~~be adelayed ~~substantial~~indefinitely. ~~depressing~~There ~~effect~~can be no assurance that we will be able to raise the funds necessary to carry out our business plan on ~~such~~terms ~~market~~favorable ~~price~~to the company, or at all.

~~Dividends~~Net Operating ~~Policy~~Loss

We have ~~never~~accumulated ~~declared~~approximately ~~cash~~$2,986,331 ~~dividends~~of onnet ~~our~~operating ~~common~~loss ~~stock~~carryforwards as of December 31, ~~nor~~2017. doThis weloss ~~anticipate~~carry ~~paying~~forward may ~~any~~be ~~dividends~~offset against taxable income and income taxes through the year 2037. The use of these losses to reduce future income taxes will depend on ~~our~~the ~~common~~generation ~~stock~~of sufficient taxable income prior to the expiration of the net operating loss carryforwards. In the event of certain changes in control, there will be an annual limitation on the ~~foreseeable~~amount of net operating loss carryforwards which can be used. No tax benefit has been reported in the financial statements for fiscal years ended December 31, 2017 and 2016 because it has been fully offset by a valuation reserve. The use of future tax benefit is undeterminable because presently we have not started full operations.

~~Item 6. Selected Financial Data.~~Inflation

~~This~~Management is ~~item~~of isthe opinion that inflation has not ~~required~~and ~~for~~will not have a ~~smaller~~material ~~reporting~~effect ~~company~~on our operations in the immediate future. We will continue to monitor inflation and evaluate the possible future effects of inflation on our business and operations.

~~Item~~Off-balance Sheet ~~7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.~~Arrangements

~~The~~We do ~~following~~not ~~discussion~~have ~~and~~any ~~analysis~~off-balance ofsheet ~~our~~arrangements ~~financial~~that ~~condition~~have ~~and~~or ~~results~~are ofreasonably ~~operations~~likely ~~should~~to behave ~~read~~a incurrent ~~conjunction~~or ~~with~~future ~~the~~effect on our financial condition, ~~statements~~changes ~~and~~in ~~notes~~financial ~~thereto~~condition, ~~appearing~~revenues ~~elsewhere~~or inexpenses, ~~this~~results ~~report~~of operations, liquidity, capital expenditures or capital resources that are material to investors.

~~We are considered an exploration stage company with no current revenues~~Item 7A. WeQuantitative ~~do not expect to realize revenues until we have completed a successful exploration program~~ and ~~are~~Qualitative ~~able~~Disclosures toAbout ~~produce~~Market ~~and market minerals in commercial quantities~~Risk. In the near term, ongoing expenses, including the costs associated with the preparation and filing reports with the SEC, will be paid for by advances from stockholders and/or directors, or possibly from the private sale of securities, either debt or equity. However, there is no assurance that we will be able to realize such funds on terms favorable to us, or at all.

~~Significant~~A registrant ~~Accounting~~that ~~Policies~~qualifies as a smaller reporting company, like this Company, as defined by § 229.10(f)(1), is not required to provide the information required by this Item.

~~Accounting~~Item 8. ~~Method~~Financial Statements and Supplementary Data.

~~These~~Financial statements ~~financial~~for ~~statements~~the fiscal years ended December 31, 2017 and ~~related~~2016 ~~notes~~have ~~are~~been ~~presented~~examined to the extent indicated in their reports by Montgomery Coscia Greilich LLP and Sadler, Gibb & Associates, L.L.C., respectively, independent accountants and have been prepared in accordance with accounting principles generally accepted in the United States. ~~The~~of ~~Company’s fiscal~~America ~~year-end~~and ispursuant ~~December~~to 31regulations promulgated by the SEC.

~~Use~~Section 302 ofdata ~~Estimates~~is not required for a smaller reporting company.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.11

~~Cash~~TABLE ~~and~~OF ~~Cash~~CONTENTS – ~~Equivalents~~FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. As of December 31, 2016 and 2015 the Company had $0 and $7 of cash and cash equivalents, respectively.

Report of Independent Registered Public Accounting Firm for the year ended December 31, 2017	13

Report of Independent Registered Public Accounting Firm for the years ended December 31, 2016 and 2015	14

Balance Sheets	15

Statements of Operations	16

Statements of Stockholders’ Deficit	17

Statements of Cash Flows	18

Notes to Financial Statements	19-22

~~Revenue Recognition~~12

~~The~~Montgomery Coscia ~~Company~~Greilich will recognize revenue from the performance of its services and/or sale of its products in accordance with ASC 605 “Revenue Recognition. Revenue will be recognized only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is provided, product is delivered, and collectability is assured.LLP

~~Advertising Costs~~972.748.0300 p

~~The Company follows the policy of expensing advertising costs during the period in which they are incurred~~972. ~~The Company incurred no advertising costs during the years ended December 31, 2016 and 2015, respectively~~748.0700 f

~~Stock-based~~REPORT OF ~~Compensation~~INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

~~The Company adopted ASC 718 effective January 1, 2006 using~~ To the ~~modified~~Board prospective method. Under this transition method, stock compensation expense includes compensation expense for all share-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ~~ASC~~Directors ~~718. During the years ending December 31, 2016~~ and ~~2015,~~Shareholders ~~the Company issued $-0- and $-0-, respectively, in share-based payments for services.~~of

~~Provision~~Protect Pharmaceutical ~~for Taxes~~Corporation:

~~The~~Opinion on ~~Company applies ASC 740, which requires~~ the ~~asset~~Financial and liability method of accounting for income taxes. The asset and liability method requires that the current or deferred tax consequences of all events recognized in the financial statements are measured by applying the provisions of enacted tax laws to determine the amount of taxes payable or refundable currently or in future years. Deferred tax assets are reviewed for recoverability and the Company records a valuation allowance to reduce its deferred tax assets when it is more likely than not that all or some portion of the deferred tax assets will not be recovered.Statements

~~Recent~~We have ~~Accounting~~audited ~~Pronouncements~~the accompanying balance sheet of Protect Pharmaceutical Corporation (the “Company”) as of December 31, 2017, and the related statements of operations, changes in stockholders’ deficit, and cash flows for the year then ended, and the related notes to the financial statements (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2017, and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.

In May 2014, the FASB issued Accounting Standards Update No. 2014-09 which was amended in August 2015 by Update No 2015-14: Revenue from Contracts with Customers. The standard outlines a five-step model Basis for revenue recognition with the core principle being that a company should recognize revenue when it transfers control of goods or services to customers at an amount that reflects the consideration to which it expects to be entitled in exchange for those goods or services. Companies can choose to apply the standard using either the full retrospective approach or a modified retrospective approach. Under the modified approach, financial statements will be prepared for the year of adoption using the new standard but prior periods presented will not be adjusted. Instead, companies will recognize a cumulative catch-up adjustment to the opening balance of retained earnings. This new guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. The Company has not yet made a determination as to the method of application (full retrospective or modified retrospective). It is too early to assess whether the impact of the adoption of this new guidance will have a material impact on the Company's results of operations or financial position.Opinion

OnThese financial ~~August~~statements ~~27,~~are ~~2014~~ the ~~FASB~~responsibility ~~issued a new financial accounting standard on going concern, Update 2014-15, “Presentation~~ of ~~Financial~~the ~~Statements~~Company’s –management. ~~Going~~Our ~~Concern~~responsibility ~~(subtopic~~is ~~205-40):~~to ~~Disclosure~~express ofan ~~Uncertainties~~opinion ~~about~~on the ~~an Entity~~Company’s ~~Ability~~financial tostatements ~~Continue~~based ason aour ~~Going Concern~~audit.” ~~The~~We ~~standard~~are ~~provides~~a ~~guidance~~public ~~about~~accounting ~~management’s~~firm ~~responsibility~~registered towith ~~evaluate~~the ~~whether~~Public ~~there~~Company Accounting isOversight ~~substantial~~Board ~~doubt~~(United ~~about~~States) ~~the~~(“PCAOB”) ~~organization’s~~and ~~ability~~are required to ~~continue~~be asindependent awith ~~going~~respect ~~concern.~~to ~~The~~the ~~amendments~~ Company in ~~this~~Accordance ~~update~~with ~~apply~~the ~~to all companies~~U.S. ~~They~~federal ~~become~~securities ~~effective~~laws inand the ~~annual~~applicable ~~period~~rules ~~ending~~and ~~after~~regulations ~~December~~of ~~15,~~the ~~2016,~~Securities ~~with~~and ~~early~~Exchange ~~application~~Commission and ~~permitted. The Company is currently evaluating~~ the ~~impact of this accounting standard~~PCAOB.

InWe conducted ~~November~~our ~~2014,~~audit ~~the~~in ~~FASB~~accordance ~~issued~~with ~~Accounting~~the ~~Standard~~standards ~~Update~~of ~~(“ASU”) 2014-16, “Determining Whether~~ the ~~Host~~PCAOB. ~~Contract~~Those instandards arequire ~~Hybrid~~that ~~Financial~~we ~~Instrument~~plan ~~Issued~~and inperform the ~~Form of a Share Is More Akin~~ audit to ~~Debt~~obtain orreasonable toassurance ~~Equity.”~~about ~~The~~whether ~~ASU clarifies how current guidance should be interpreted in evaluating~~ the ~~economic~~financial ~~characteristics~~statements ~~and~~are ~~risks~~free of amaterial ~~host~~misstatement, ~~contract~~whether indue ato ~~hybrid~~error or ~~financial~~fraud. ~~instrument~~The ~~that~~Company is ~~issued~~not inrequired ~~the~~to ~~form of a share. Specifically~~have, ~~the~~nor ~~amendments~~were ~~clarify~~we ~~that~~engaged anto ~~entity should consider all relevant terms and features~~perform, ~~including~~an ~~the~~audit ~~embedded~~of ~~derivatives~~its ~~feature~~internal ~~being~~control ~~evaluated~~over ~~for~~financial reporting. ~~bifurcation,~~Our inaudit ~~evaluating~~included ~~the~~consideration ~~nature~~ of ainternal ~~host~~control ~~contract.~~over ~~The~~financial ~~ASU~~reporting isas ~~effective~~a basis for ~~fiscal~~designing ~~years~~audit ~~beginning~~procedures that ~~after~~are ~~December~~appropriate ~~15,~~in ~~2015~~the ~~and interim periods beginning after December 15~~circumstances, ~~2016.~~but ~~The~~not ~~Company~~for ~~has~~the ~~determined~~purpose ~~there~~of isexpressing noan ~~material~~opinion ~~impact~~on to the ~~accounting~~effectiveness ~~treatment~~ of ~~its~~the ~~hybrid~~Company’s internal control over financial ~~instruments~~reporting. ~~based~~Accordingly, onwe ~~this~~express ~~new~~no ~~standard~~such opinion.

~~Management~~Our audit ~~has~~included ~~considered all~~performing ~~recent accounting~~procedures ~~pronouncements~~to ~~issued~~assess ~~since~~ the ~~last~~risks ~~audit~~of material misstatement of the ~~Company’s~~ financial statements., ~~The~~whether ~~Company’s~~due ~~management~~to error ~~believes~~or fraud, and performing procedures that ~~these~~respond ~~recent~~to ~~pronouncements~~those ~~will~~risks. ~~not~~Such ~~have~~procedures included examining, on a ~~material~~test ~~effect~~basis, onevidence regarding the ~~Company’s~~amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provide a reasonable basis for our opinion.

~~Results of Operations~~Other Matter

WeAs discussed ~~did~~in ~~not~~Note ~~realize~~2 ~~revenues~~to ~~for~~ the ~~years~~financial ~~ended~~statements, ~~December~~the ~~31,~~accompanying ~~2016~~financial ~~and~~statements ~~2015.~~have ~~Operating~~been ~~expenses~~prepared ~~totaled~~assuming ~~$41,707~~that ~~and~~the ~~$30,027~~Company will ~~for~~continue ~~2016~~as ~~and~~a ~~2015,~~going ~~respectively~~concern. ~~Our~~The ~~2016~~Company ~~expenses~~has ~~consisted~~no ~~$37,225~~assets innor ~~professional~~does ~~fees,~~it ~~$4,150~~have inan ~~executive~~established ~~compensation~~source ~~and~~of ~~$332~~revenue into ~~general~~cover ~~and~~its ~~administrative~~operating costs, ~~expenses.~~which ~~Our~~raises ~~2015~~substantial ~~expenses~~doubt ~~consisted~~about ~~$22,085~~its inability ~~professional~~to ~~fees,~~continue ~~$6,000~~as ina ~~executive~~going ~~compensation~~concern. ~~and~~Management’s ~~$1,942~~plan in ~~general~~regard ~~and~~to ~~administrative~~these matters ~~expenses~~are described in Note 2. The ~~increase~~financial instatements ~~professional~~do ~~fees~~not ~~for~~include ~~2016~~any ~~was~~adjustments ~~attributed~~ to ~~increased~~reflect ~~legal,~~the ~~transfer~~outcome ~~agent~~of ~~and~~this ~~accounting~~uncertainty. Our ~~fees~~opinion ~~associated~~is ~~with~~not ~~our~~modified ~~reporting~~with ~~requirements~~respect ~~with~~to ~~the~~this ~~SEC~~matter.

~~Liquidity~~/s/ Montgomery ~~and~~Coscia ~~Capital~~Greilich, ~~Resources~~LLP

~~Total~~We have ~~assets~~served ~~consisting~~as ~~solely of cash at December 31, 2016 and 2015 were $-0- and $7, respectively. Total liabilities at December 31, 2016 and 2015 were $20,830 and $100,454, respectively. The decrease in liabilities at~~ the ~~end~~Company’s ofAuditor ~~2016~~since ~~is primarily attributed to the payment of accounts payable by a former shareholder.~~ 2018

10Plano, TX

~~Because currently we have no revenues or significant cash reserves~~February 15, for the immediate future we will rely on our directors and/or stockholders to pay expenses or raise funds through the private placement of securities. There is no assurance that we will be able to raise adequate capital in the immediate future to satisfy cash needs. At December 31, 2016, we had total stockholders’ deficit of $20,830 compared to a stockholders’ deficit of $100,447 at December 31, 2015. 2019

~~Plan of Operation~~13

~~General~~REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Our current purpose is to seek, investigate and, if such investigation warrants, merge or acquire an interest in business opportunities presented to it by persons or companies who or which desire to seek To the ~~perceived~~Board ~~advantages~~ of anDirectors ~~Exchange Act registered corporation. As of the date of this Annual Report, our management has no particular acquisitions in mind~~ and ~~has~~Shareholders ~~not entered into any negotiations regarding such an acquisition, and neither our sole officer or our directors nor any promoter and affiliate has engaged in any negotiations with any representatives~~ of ~~the owners of any business or company regarding the possibility of a merger or acquisition between us and such other company.~~

~~Pending~~Protect Pharmaceutical negotiation and consummation of a combination, we anticipate that we will have, aside from carrying on our search for a combination partner, no business activities, and, thus, will have no source of revenue. Should we incur any significant liabilities prior to a combination with a private company, it may not be able to satisfy such liabilities as are incurred.Corporation

IfWe have ~~our~~audited ~~management~~the ~~pursues~~accompanying ~~one~~balance orsheets ~~more~~of ~~combination~~Protect ~~opportunities~~Pharmaceutical ~~beyond~~Corporation (“the ~~preliminary~~Company”) ~~negotiations~~as ~~stage~~of ~~and~~December 31, ~~those~~2016 ~~negotiations~~and ~~are subsequently terminated~~2015, itand isthe ~~foreseeable~~related ~~that~~statements ~~such~~of ~~efforts~~operations, ~~will~~stockholders’ ~~exhaust~~deficit, ~~our~~and ~~ability~~cash toflows ~~continue~~for toeach ~~seek~~of ~~such~~the ~~combination~~years in ~~opportunities~~the ~~before~~two ~~any~~year ~~successful~~period ~~combination~~ended ~~can~~December be31, ~~consummated~~2016. InThese ~~that~~financial ~~event,~~statements ~~our~~are ~~common~~the ~~stock~~responsibility ~~will~~of ~~become~~the ~~worthless~~Company’s ~~and~~management. Our ~~holders~~responsibility ofis ~~our~~to ~~common~~express ~~stock~~an ~~will~~opinion ~~receive~~on athese ~~nominal~~financial ~~distribution,~~statements ifbased ~~any,~~on ~~upon~~ our ~~liquidation and dissolution~~audits.

~~Net~~We conducted ~~Operating~~our ~~Loss~~audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

WeIn our ~~have accumulated approximately $2~~opinion,~~943,417~~ ~~of net operating loss carryforwards as of December 31, 2016. This loss carry forward may be offset against taxable income and income taxes through~~ the ~~year~~financial ~~2036.~~statements ~~The~~referred ~~use of these losses~~ to ~~reduce~~above ~~future~~present ~~income~~fairly, ~~taxes~~in ~~will~~all ~~depend~~material onrespects, the ~~generation~~financial ofposition ~~sufficient taxable income prior to the expiration~~ of ~~the~~Protect Pharmaceutical ~~net~~Corporation ~~operating~~as ~~loss carryforwards. In the event~~ of ~~certain~~December ~~changes in control~~31, ~~there~~2016 ~~will~~and be2015, anand ~~annual limitation on~~ the ~~amount~~results of ~~net~~its ~~operating~~operations ~~loss~~and ~~carryforwards~~its ~~which~~cash ~~can~~flows befor ~~used.~~each Noof the ~~tax~~years ~~benefit has been reported~~ in the ~~financial~~two ~~statements~~year ~~for~~period ~~fiscal years~~ ended December 31, 2016, ~~and~~in ~~2015~~conformity ~~because~~with itaccounting ~~has~~principles ~~been~~generally ~~fully~~accepted ~~offset~~in bythe aUnited States ~~valuation reserve. The use~~ of ~~future tax benefit is undeterminable because presently we have not started full operations~~America.

~~Inflation~~The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company has suffered net losses since inception and has accumulated a significant deficit. These factors raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

~~Management~~/s/ Sadler, isGibb of& ~~the~~Associates, opinion that inflation has not and will not have a material effect on our operations in the immediate future. We will continue to monitor inflation and evaluate the possible future effects of inflation on our business and operations.LLC

~~Off-balance~~Salt Lake ~~Sheet~~City, ~~Arrangements~~UT

WeMarch 31, ~~have no off-balance sheet arrangements.~~2017

~~JOBS Act~~14

~~The~~Protect Pharmaceutical ~~JOBS Act provides that, so long as a company qualifies as an “emerging growth company,” it will, among other things:~~Corporation

●Balance Sheets

be exempt from the provisions of Section 404(b) of the Sarbanes-Oxley Act requiring that its independent registered public accounting firm provide an attestation report on the effectiveness of its internal control over financial reporting;

	December 31, 2017			December 31, 2016

ASSETS
Current assets
Cash	$	-		$	-
Total current assets	$	-		$	-
TOTAL ASSETS	$	-		$	-

LIABILITIES
Current liabilities
Accounts payable & accrued expenses	$	950		$	9,950
Related party payables		35,280			10,880
Interest payable		6,211			-
Total current liabilities	$	42,441		$	20,830
Long-term liabilities
Notes payable	$	101,000		$	-
Total long-term liabilities	$	101,000		$	-

TOTAL LIABILITIES	$	143,441		$	20,830

STOCKHOLDERS’ DEFICIT
Preferred stock: 10,000,000 shares authorized, at $0.001 par value; 0 shares issued or outstanding as of December 31, 2017 and 2016	$	-		$	-
Common stock: 100,000,000 shares authorized at $0.005 par value; 1,111,460 shares issued and outstanding as of December 31, 2017 and 2016		5,557			5,557
Additional paid-in capital		9,365,612			9,365,612
Accumulated deficit		(9,514,610	)		(9,391,999	)
TOTAL STOCKHOLDERS’ DEFICIT	$	(143,441	)	$	(20,830	)

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	-		$	-

●The accompanying notes are an integral part of these financial statements.

be exempt from the “say on pay” and “say on golden parachute” advisory vote requirements of the Dodd-Frank Wall Street Reform and Customer Protection Act (the “Dodd-Frank Act”), and certain disclosure requirements of the Dodd-Frank Act relating to compensation of its chief executive officer and be permitted to omit the detailed compensation discussion and analysis rom proxy statements and reports filed under the Securities Exchange Act of 1934; and15

●Protect Pharmaceutical Corporation

~~instead provide a reduced level~~ Statements of disclosure concerning executive compensation and be exempt from any rules that may be adopted by the Public Company Accounting Oversight Board requiring mandatory audit firm rotations or a supplement to the auditor’s report on the financial statements. Operations

It should be noted that notwithstanding our status as an emerging growth company, we would be eligible for these exemptions as a result of our status as a “smaller reporting company” as defined by the Securities Exchange Act of 1934.

	For the year ended
	December 31,
	2017			2016

REVENUES	$	-		$	-

OPERATING EXPENSES
Professional fees		115,200			37,225
Executive compensation		-			4,150
General & administrative		200			332
TOTAL OPERATING EXPENSES	$	115,400		$	41,707

OPERATING LOSS	$	(115,400	)	$	(41,707	)

Interest expense		7,211			-

LOSS BEFORE TAXES	$	(122,611	)	$	(41,707	)

Taxes		-			-

NET LOSS	$	(122,611	)	$	(41,707	)

BASIC LOSS PER SHARE OF COMMON STOCK	$	(0.11	)	$	(0.04	)

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING		1,111,460			1,111,460

DILUTED LOSS PER SHARE OF COMMON STOCK	$	(0.10	)	$	(0.04	)

DILUTED WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING		1,204,815			1,111,460

~~Section~~The accompanying ~~107~~notes ofare ~~the JOBS Act provides that~~ an ~~emerging~~integral ~~growth~~part ~~company can take advantage~~ of ~~the~~these ~~extended~~financial ~~transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards~~statements. An emerging growth company can therefore delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected not to take advantage of the benefits of this extended transition period and, therefore, will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.

~~Cautionary Statement Concerning Forward-Looking Information~~16

~~This~~Protect Pharmaceutical report contains forward-looking statements relating to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “will” “should," “expect," "intend," "plan," anticipate," "believe," "estimate," "predict," "potential," "continue," or similar terms, variations of such terms or the negative of such terms. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including those risks discussed in the “Risk Factors” section above. Although forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment, actual results could differ materially from those anticipated in such statements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.Corporation

~~Item~~Statements of ~~7A.~~Stockholders’ ~~Quantitative and Qualitative Disclosures About Market Risk.~~Deficit

This item is not required for a smaller reporting company.

					Additional					Total
	Common Stock				Paid-In		Accumulated			Stockholders’
	Shares		Amount		Capital		Deficit			Deficit

Balance, December 31, 2015		1,111,460	$	5,557	$	9,244,288	$	(9,350,292	)	$	(100,447	)

Services contributed by officers						4,150					4,150

Accounts payable paid by shareholder						72,225					72,225

Forgiveness of related party notes payable						44,949					44,949

Net loss for the year ended December 31, 2016								(41,707	)		(41,707	)

Balance, December 31, 2016		1,111,460	$	5,557	$	9,365,612	$	(9,391,999	)	$	(20,830	)

Net loss for the year ended December 31, 2017								(122,611	)		(122,611	)

Balance, December 31, 2017		1,111,460	$	5,557	$	9,365,612	$	(9,514,610	)	$	(143,441	)

~~Item~~The accompanying 8.notes ~~Financial~~are ~~Statements~~an ~~and~~integral ~~Supplementary~~part ~~Data.~~of these financial statements

Financial statements for the fiscal years ended December 31, 2016 and 2015 have been examined to the extent indicated in their reports by Sadler, Gibb & Associates, L.L.C, independent registered public accountants and have been prepared in accordance with accounting principles generally accepted in the United States of America and pursuant to regulations promulgated by the SEC.17

~~REPORT~~Protect Pharmaceutical ~~OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM~~Corporation

~~To the Board~~ Statements of ~~Directors~~Cash ~~and Shareholders of~~Flows

Protect Pharmaceutical Corporation

	For the year ended
	December 31,
	2017			2016
OPERATING ACTIVITIES
Net loss	$	(122,611	)	$	(41,707	)

Adjustments to reconcile net loss to net cash provided by operations:
Convertible note issued for professional services	$	101,000		$	-
Capital contributed by a shareholder		-			4,150
Expenses paid on behalf of the company		-			10,000
Changes in operating assets and liabilities:
Accounts payable		(9,000	)		13,399
Accounts payable - related party		24,400			-
Interest payable		6,211			-
Total adjustments to reconcile net loss to net cash provided by operations:		122,611			27,549

Net cash used in operating activities	$	-		$	(14,158	)

INVESTING ACTIVITIES

Net cash provided by investing activities	$	-		$	-

FINANCING ACTIVITIES
Advances from related party		-			14,151

Net cash provided by financing activities	$	-		$	14,151

NET CHANGE IN CASH	$	-		$	(7	)

CASH AT BEGINNING OF PERIOD		-			7
CASH AT END OF PERIOD		-			-

SUPPLEMENTAL CASH FLOW INFORMATION:

NON-CASH FINANCING ACTIVITIES

Convertible note issued for professional services	$	101,000		$	-

~~We have audited the~~ The accompanying ~~balance~~notes sheets of Protect Pharmaceutical Corporation (“the Company”) as of December 31, 2016 and 2015, and the related statements of operations, stockholders’ deficit, and cash flows for each of the years in the two year period ended December 31, 2016. These financial statements are ~~the responsibility of the Company’s management. Our responsibility is to express~~ an ~~opinion~~integral onpart of these financial statements ~~based on our audits~~.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.18

InNOTE 1 ~~our~~- ~~opinion,~~FINANCIAL the financial statements referred to above present fairly, in all material respects, the financial position of Protect Pharmaceutical Corporation as of December 31, 2016 and 2015, and the results of its operations and its cash flows for each of the years in the two year period ended December 31, 2016, in conformity with accounting principles generally accepted in the United States of America.STATEMENTS

The accompanying financial statements have been prepared ~~assuming~~by ~~that~~ the Company ~~will~~without ~~continue as a going concern~~audit. AsIn ~~discussed in Note 3 to~~ the ~~financial~~opinion ~~statements~~of management, ~~the~~all ~~Company~~adjustments (which ~~has~~include ~~suffered~~only ~~net~~normal ~~losses~~recurring ~~since~~adjustments) ~~inception~~necessary ~~and has accumulated a significant deficit. These factors raise substantial doubt about its ability~~ to ~~continue~~present asfairly athe ~~going~~financial ~~concern.~~position, ~~Management’s~~results ~~plans~~of inoperations, ~~regard~~and cash toflows ~~these~~at ~~matters~~December ~~are~~31, ~~also~~2017 ~~described~~and infor ~~Note~~all 3.periods ~~The~~presented ~~financial~~herein, ~~statements~~have dobeen ~~not include any adjustments that might result from the outcome of this uncertainty~~made.

~~/s/~~NOTE 2 ~~Sadler,~~- ~~Gibb~~GOING ~~& Associates, LLC~~CONCERN

~~Salt~~The Company’s ~~Lake~~financial ~~City~~statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, UTthe Company does not have significant cash or other material assets, nor does it have an established source of revenues sufficient to cover its operating costs and to allow it to continue as a going concern. It is the intent of the Company to seek a merger with an existing, operating company. In the interim, shareholders of the Company have committed to meeting its minimal operating expenses.

~~March~~In addition, 31the inability of The Company to become current in periodic reporting obligations under the federal securities laws during the fourth quarter limited the information that the Company was able to provide to the public, ~~2017~~to investors and to other interested parties, including customers and certain lenders. Furthermore, such inability to become current limited the Company’s ability to use equity incentives to attract, retain and motivate employees. Such inability to become current also restricted the Company’s ability to raise capital through the issuance of equity or debt securities, use equity securities for acquisitions of complementary companies and businesses and engage in other strategic transactions.

PROTECT PHARMACEUTICAL CORPORATION
Balance Sheets
ASSETS
			December 31,		December 31,
			2016		2015
CURRENT ASSETS
	Cash		$	-	$	7
		Total Current Assets		-		7
		TOTAL ASSETS	$	-	$	7
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES
	Accounts payable and accrued expenses		$	9,950	$	69,656
	Related party payables			10,880		30,798
		Total Current Liabilities		20,830		100,454
		TOTAL LIABILITIES		20,830		100,454
STOCKHOLDERS' DEFICIT
	Preferred stock; 10,000,000 shares authorized,
	at $0.001 par value, no shares issued or outstanding			-		-
	Common stock; 100,000,000 shares authorized,
	at $0.005 par value, 1,111,460 and 1,111,460
	shares issued and outstanding, respectively			5,557		5,557
	Additional paid-in capital			9,365,612		9,244,288
	Accumulated deficit			(9,391,999)		(9,350,292)
		Total Stockholders' Deficit		(20,830)		(100,447)
		TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	-	$	7
The accompanying notes are an integral part of these financial statements.

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES

PROTECT PHARMACEUTICAL CORPORATION
Statements of Operations
		For the Years Ended
		December 31,
		2016		2015
REVENUES		$	-	$	-
EXPENSES
	Professional Fees		37,225		22,085
	Executive compensation		4,150		6,000
	General and administrative		332		1,942
LOSS FROM OPERATIONS			(41,707)		(30,027)
OTHER INCOME
	Loss on settlement of debt		-		(605,437)
INCOME (LOSS) BEFORE INCOME TAXES			(41,707)		(635,464)
	Income Taxes		-		-
NET INCOME (LOSS)		$	(41,707)	$	(635,464)
BASIC AND DILUTED INCOME (LOSS) PER SHARE OF
	COMMON STOCK	$	(0.04)	$	(1.44)
WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING			1,111,460		442,169
The accompanying notes are an integral part of these financial statements.

Accounting Method

PROTECT PHARMACEUTICAL CORPORATION
Statements of Stockholders' Equity (Deficit)
				Additional				Total
	Common Stock			Paid-In		Accumulated		Stockholders'
	Shares	Amount		Capital		Deficit		Deficit
Balance, December 31, 2014	89,459	$	447	$	8,593,398	$	(8,714,828)	$	(120,983)
Services contributed by officers	-		-		6,000		-		6,000
Rounding shares issued	22,001		110		(110)		-		-
Comon stock issued for
settlement of debt	1,000,000		5,000		645,000		-		650,000
Net loss for the year ended
December 31, 2015	-		-		-		(635,464)		(635,464)
Balance, December 31, 2015	1,111,460	$	5,557	$	9,244,288	$	(9,350,292)	$	(100,447)
Services contributed by officers	-		-		4,150		-		4,150
Accounts payable paid by shareholder	-		-		72,225		-		72,225
Forgiveness of related party notes payable					44,949				44,949
Net loss for the year ended
December 31, 2016	-		-		-		(41,707)		(41,707)
Balance, December 31, 2016	1,111,460		5,557		9,365,612		(9,391,999)		(20,830)

These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States. The Company’s fiscal year-end is December 31.

PROTECT PHARMACEUTICAL CORPORATION
Statements of Cash Flows
			For the Year Ended
			December 31,
			2016		2015
OPERATING ACTIVITIES
Net loss			$	(41,707)	$	(635,464)
Adjustments to reconcile loss
to cash flows from operating activities
	Capital contributed by an shareholder			4,150		6,000
	Loss on settlement of debt			-		605,436
	Expenses paid on behalf of the Company			10,000		-
Changes in operating assets and liabilities
	Accounts payable			13,399		(3,330)
	Accounts payable - related party			-		9,553
		Net Cash Used in Operating Activities		(14,158)		(17,805)
INVESTING ACTIVITIES
		Net Cash Provided by (Used in) Investing Activities		-		-
FINANCING ACTIVITIES
	Advances from related party			14,151		17,310
		Net Cash Provided by Financing Activities		14,151		17,310
NET CHANGE IN CASH				(7)		(495)
CASH AT BEGINNING OF PERIOD				7		502
CASH AT END OF PERIOD			$	-	$	7
SUPPLEMENTAL CASH FLOW INFORMATION:
	NON-CASH FINANCING ACTIVITIES:
		Cash paid for interest	$	-	$	-
		Cash paid for income taxes	$	-	$	-
		Share issued for rounding in reverse split	$	-	$	110
		Common stock issued for settlement of debt	$	-	$	650,000
		Accounts Payable Paid by shareholder	$	73,105	$	-
		Forgiveness of related-party notes payable	$	44,949	$	-
The accompanying notes are an integral part of these financial statements.

Use of Estimates

~~NOTE~~The preparation 1of -financial ~~ORGANIZATION~~statements ~~AND~~in ~~HISTORY~~conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

~~Business~~ Cash and ~~Organization~~Cash Equivalents

~~Protect Pharmaceutical Corporation (the~~ The Company~~) was~~ ~~originally~~considers ~~incorporated~~all ~~under~~highly ~~the~~liquid ~~laws~~instruments ofwith ~~the~~maturity ~~state~~ of ~~Idaho~~three onmonths ~~August~~or 5,less ~~1987. The~~at ~~Company was incorporated for~~ the ~~purpose~~time of ~~purchasing,~~issuance ~~leasing~~to orbe ~~otherwise~~cash ~~acquiring~~equivalents. As ~~mining~~of ~~claims~~December ~~and~~31, ~~rights~~2017 and ~~also~~2016 tothe ~~develop mines. The~~ Company ~~was~~had ~~unable~~$0 toand ~~raise~~$0 ~~development~~of ~~money~~cash and ~~the~~cash ~~Company’s operations ceased. The Company has been seeking new business opportunities believed to hold a potential profit or to merge with an existing~~equivalents, ~~operating company~~respectively.

On June 15, 2006, the name of the Company changed to Pro-Tect, Inc. and its domicile was moved to the state of Nevada. Subsequently, the Company changed its name on March 25, 2010 to Protect Pharmaceutical Corporation. Since that date the Company has engaged in licensing its patented pharmaceuticals technologies.Revenue Recognition

~~NOTE~~The Company ~~2 – SUMMARY~~will OFrecognize ~~SIGNIFICANT~~revenue ~~ACCOUNTING~~from ~~POLICIES~~the performance of its services and/or sale of its products in accordance with ASC 605 “Revenue Recognition. Revenue will be recognized only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is provided, product is delivered, and collectability is assured.

~~Accounting~~Revenue from ~~Method~~Contracts with Customers

~~These~~The Company ~~financial~~applies ~~statements~~Accounting ~~and~~Standards ~~related~~Update ~~notes~~No. ~~are~~2014-09 ~~presented~~which was amended in ~~accordance~~August 2015 by Update No 2015-14: Revenue from Contracts with ~~accounting~~Customers. ~~principles~~The ~~generally~~standard ~~accepted~~outlines ina five-step model for revenue recognition with the ~~United~~core ~~States~~principle being that a company should recognize revenue when it transfers control of goods or services to customers at an amount that reflects the consideration to which it expects to be entitled in exchange for those goods or services. This new guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. The Company~~’s fiscal~~ adopted this standard on April 1, 2017 and has chosen to apply the standard using modified retrospective approach. Under the modified approach, financial statements are prepared for the year of adoption using the new standard, but prior periods presented will not be adjusted. The Company also determined that a cumulative catch-~~end~~up isadjustment ~~December~~to 31the opening balance of retained earnings was not necessary due to a lack of revenue in 2017.

~~Use of Estimates~~19

~~Cash~~The Company follows the policy of expensing advertising costs during the period in which they are incurred. The Company incurred no advertising costs during the years ended December 31, 2017 and ~~Cash~~2016, ~~Equivalents~~respectively.

~~Revenue~~The Company ~~Recognition~~adopted ASC 718 effective January 1, 2006 using the modified prospective method. Under this transition method, stock compensation expense includes compensation expense for all share-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 718. During the years ending December 31, 2017 and 2016, the Company issued $0 and $0, respectively, in share-based payments for services.

~~The~~Provision for Company will recognize revenue from the performance of its services and/or sale of its products in accordance with ASC 605 “Revenue Recognition”. Revenue will be recognized only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is provided, product is delivered, and collectability is assured.Taxes

~~Advertising~~The Company ~~Costs~~applies ASC 740, which requires the asset and liability method of accounting for income taxes. The asset and liability method requires that the current or deferred tax consequences of all events recognized in the financial statements are measured by applying the provisions of enacted tax laws to determine the amount of taxes payable or refundable currently or in future years. Deferred tax assets are reviewed for recoverability and the Company records a valuation allowance to reduce its deferred tax assets when it is more likely than not that all or some portion of the deferred tax assets will not be recovered.

The Company follows the policy of expensing advertising costs during the period in which they are incurred. The Company incurred no advertising costs during the years ended December 31, 2016 and 2015, respectively.Going Concern

~~NOTE~~The Company ~~2 – SUMMARY~~applies OFAccounting ~~SIGNIFICANT~~Standards ~~ACCOUNTING~~Update ~~POLICIES~~2014-15, “Presentation of Financial Statements – Going Concern (~~CONTINUED~~subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” The standard provides guidance about management’s responsibility to evaluate whether there is substantial doubt about the organization’s ability to continue as a going concern. The amendments in this update apply to all companies. They become effective in the annual period ending after December 15, 2016, with early application permitted. The Company adopted this standard on December 15, 2016.

~~Stock-based~~Basic Loss ~~Compensation~~per Common Share

~~The~~Basic loss per share is calculated by dividing the Company’s ~~adopted~~net ~~ASC~~loss ~~718~~applicable ~~effective~~to ~~January 1,~~common ~~2006~~shareholders ~~using~~by the ~~modified~~weighted ~~prospective~~average number ~~method~~of common shares during the period. ~~Under~~Diluted ~~this~~earnings ~~transition~~per ~~method,~~share ~~stock~~is ~~compensation~~calculated ~~expense~~by ~~includes~~dividing ~~compensation~~the ~~expense~~Company’s ~~for~~net ~~all~~income available ~~share-based~~to ~~compensation~~common ~~awards~~shareholders ~~granted~~by onthe ordiluted ~~after~~weighted ~~January 1,~~average ~~2006,~~number ~~based~~of onshares outstanding during the ~~grant-date~~year. ~~fair~~The ~~value~~diluted ~~estimated~~weighted average innumber ~~accordance~~of ~~with~~shares outstanding is the ~~provisions~~basic weighted number of ~~ASC~~shares ~~718~~adjusted for any potentially dilutive debt or equity. There ~~During~~was ~~the~~a ~~years~~convertible ~~ending~~note ~~December~~in ~~31,~~default ~~2016~~as ~~and~~of ~~2015~~December 31, ~~the~~2017 ~~Company~~that ~~issued~~was ~~$-0-~~subsequently ~~and~~converted ~~$-0-,~~into ~~respectively~~246,918 inshares ~~share-based~~of ~~payments~~common stock ~~for~~on ~~services~~December 11, 2018.

Provision for Taxes

	For the year ended
	December 31,
	2017			2016
BASIC LOSS PER COMMON SHARE
Net loss (numerator)	$	(122,611	)	$	(41,707	)
Common shares outstanding (denominator)		1,111,460			1,111,460
Per share amount	$	(0.11	)	$	(0.04	)

DILUTED LOSS PER COMMON SHARE
Net loss (numerator)	$	(122,611	)	$	(41,707	)
Common shares outstanding (denominator)		1,204,815			1,111,460
Per share amount	$	(0.10	)	$	(0.04	)

~~The~~Convertible notes ~~Company~~with ~~applies~~fixed ~~ASC~~rate ~~740,~~conversion which requires the asset and liability method of accounting for income taxes. The asset and liability method requires that the current or deferred tax consequences of all events recognized in the financial statements are measured by applying the provisions of enacted tax laws to determine the amount of taxes payable or refundable currently or in future years. Deferred tax assets are reviewed for recoverability and the Company records a valuation allowance to reduce its deferred tax assets when it is more likely than not that all or some portion of the deferred tax assets will not be recovered.options

~~Basic~~The Company ~~Income~~may ~~(Loss)~~enter ~~per~~into ~~Common~~convertible ~~Share~~notes, some of which contain, predominantly, fixed rate conversion features, whereby the outstanding principal and accrued interest may be converted by the holder, into common shares at a fixed discount to the market price of the common stock at the time of conversion. This results in a fair value of the convertible note being equal to a fixed monetary amount. The Company records the convertible note liability at its fixed monetary amount by measuring and recording a discount, as applicable, on the Note date with a charge of interest expense in accordance with ASC 480 – “Distinguishing Liabilities from Equity.”

Basic income (loss) per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year.20

~~The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive~~ Convertible debt ~~or equity. There are no such common stock equivalents outstanding as of December 31, 2016 and 2015.~~

	For the Year Ended December 31, 2016						For the Year Ended December 31, 2015
Income (Loss) (numerator)	$		(41,707		)	$		(635,464				)
Shares (denominator)				1,111,460							442,169
Per share amount		$		(0.04					)	$	(1.44		)

In July 2017, the FASB issued Accounting Standards Update No. 2017-11 Earnings Per Share (Topic 260) Distinguishing Liabilities from Equity (Topic 480) Derivatives and Hedging (Topic 8115) (“ASU 2017-11”), which changes the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. ASU 2017-11 also clarifies existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, ASU 2017-11 requires entities to present earnings per share (EPS) in accordance with ASC Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. For the Company, ASU 2017-11 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted, including adoption in an interim period. The Company adopted this standard on July 1, 2017, and applied it retroactively to the Company’s financial reporting starting on April 1, 2017.

Recent Accounting Pronouncements

Management has considered all other recent accounting pronouncements issued since the last audit of the Company’s financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.

NOTE 4 3 – ~~GOING~~ ~~CONCERN~~RELATED-PARTY TRANSACTIONS

The Company’s ~~financial~~has ~~statements~~recorded ~~are~~advances ~~prepared~~from ~~using~~related ~~accounting~~parties ~~principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets~~ and ~~liquidation~~expenses ofpaid ~~liabilities~~by inrelated ~~the~~parties ~~normal~~on ~~course~~behalf of ~~business. However,~~ the Company ~~the~~as ~~Company~~related ~~has~~party payables. anAs ~~accumulated deficit~~ of $9December 31,~~391,999 as~~ of2017 and December 31, 2016, ~~which~~respectively, ~~raises~~the ~~substantial~~related ~~doubt~~party ~~about~~payable ~~its~~outstanding ~~ability~~balance tototaled ~~continue~~$35,280 and as$10,880, ~~a going concern~~respectively. It isThese ~~the~~payables ~~intent~~are ofnon-interest ~~the Company to seek a merger with an existing~~bearing, ~~operating company. In the interim~~unsecured, ~~shareholders~~and ofare ~~the~~due ~~Company~~on ~~have committed to meeting its minimal operating expenses~~demand.

NOTE 5 4 – ~~RELATED~~ ~~PARTY TRANSACTIONS~~CONVERTIBLE NOTES

~~The~~On April 15, 2017, the Company ~~has~~issued ~~recorded~~a ~~advances~~convertible ~~from~~promissory ~~related~~note ~~parties~~(the ~~and~~“Convertible ~~expenses~~Note”) ~~paid~~for by$101,000 ~~related~~($100,000 ~~parties~~principal plus ona ~~behalf~~1% oforiginal ~~the~~issue ~~Company~~discount) asto ~~related~~Trident ~~party~~Cap ~~payables~~X Corp. As(“Trident”), ofa ~~December~~Florida ~~31,~~Limited ~~2016~~Liability ~~and~~Company. ~~December~~The ~~31,~~Convertible Note ~~2015~~has a maturity date of October 15, ~~respectively~~2017, with a 15% interest rate in the ~~related~~case ~~party~~that ~~payable~~the ~~outstanding~~principle ~~balance~~is ~~totaled~~not ~~$8,880 and~~paid ~~$30,798~~off in full by the maturity date. ~~These~~The ~~payables~~value ~~are~~of ~~non-interest~~the ~~bearing~~Convertible Note, ~~unsecured~~plus the amount of all expenses incurred by the Holder relating to the conversion of this Note into shares of Common Stock, ~~and~~can ~~are~~be ~~due~~converted oninto ~~demand~~shares of PRTT Common Stock at $0.0001 par value per share.

~~See~~On February ~~also~~8, 2018, Trident assigned the Convertible Note 5to ~~for~~Global ~~related~~Startup ~~party~~League ~~equity~~LLC ~~transactions~~(“Global”) a Florida Limited Liability Company.

~~NOTE~~On August ~~5 – STOCKHOLDERS~~6, 2018, GLOBAL filed a Complaint in the Superior Court for the District of Columbia, styled Global Startup League, LLC v. Protect Pharmaceutical Corporation, alleging that the Company had breached the Convertible Note and owed Global $100,000, plus default interest of at least 15% annually as provided for in the Convertible Note, along with the related attorney’ ~~EQUITY~~s fees.

OnThe Company ~~June~~reached ~~20,~~a ~~2011,~~settlement ~~the~~with ~~Company~~Global ~~received~~on ~~written~~September ~~consent~~14, ~~from~~2018, including ~~its~~a ~~majority~~release, ~~stockholders~~and tohad ~~amend the Company~~PRTT’s ~~articles~~transfer ofagent ~~incorporation~~issue to246,918 ~~change~~shares ~~the~~of ~~authorized~~Common ~~capitalization.~~Stock ~~The~~to ~~board~~Global ofto ~~directors~~satisfy ~~previously approved~~ the ~~resolution~~obligation. Interest topayable ~~increase~~on the ~~number~~Convertible ofNote ~~authorized~~as ~~common~~of ~~stock~~December ~~from 50~~31,~~000,000~~ to2017 ~~100,000,000 shares~~ and to2016 ~~authorize~~was 10$6,~~000,000~~211 ~~shares~~and ~~of “blank~~$0, ~~check” preferred shares~~respectively.

~~The~~NOTE 6 ~~authorized~~– ~~preferred~~INCOME shares may be issued from time to time in one or more series in the discretion of the board of directors. The board will have the authority to establish the number of shares to be included in each such series, and to fix the designation, powers, preferences and rights of the shares of each such series and the qualifications, limitations and restrictions thereof.TAXES

OnThe Company ~~September~~provides 1,for ~~2015~~income ~~the~~taxes ~~Company~~under ~~issued~~ASC an740 ~~aggregate~~“Tax ofProvisions.” ~~1,000,000~~ASC ~~shares~~740 ofrequires ~~common~~the ~~stock~~use toof ~~related~~an ~~parties~~asset asand ~~payment~~liability approach onin aaccounting ~~note~~for ~~payable~~income ~~with~~taxes. aDeferred ~~balance~~tax ofassets ~~$44,563. The~~and ~~shares~~liabilities ~~were~~are ~~valued~~recorded atbased ~~$0.65~~on ~~per~~the ~~share,~~differences ~~resulting~~between inthe financial astatement ~~total~~and ~~payment~~tax ~~value~~bases of ~~$650,000. The~~assets ~~transaction~~and ~~resulted~~liabilities inand the ~~Company~~tax ~~recording~~rates ain ~~loss~~effect onwhen ~~settlement~~these ofdifferences ~~debt~~are inexpected ~~the amount of $605,437~~to reverse.

~~During~~ASC 740 ~~the~~requires ~~twelve months ended December 31, 2016, $72,225 of~~ the ~~accounts~~reduction ~~payable~~ of ~~the~~deferred ~~Company~~tax ~~was~~assets ~~paid~~ by a ~~significant~~valuation ~~shareholder.~~allowance ~~Also~~if, ~~during~~based on the ~~twelve~~weight ~~months~~of ~~ended~~available ~~September 30~~evidence, ~~2016,~~it ~~$44,949~~is more inlikely ~~related-party~~than ~~notes~~not ~~payable~~that ~~were~~some ~~forgiven~~or byall of the ~~Company’s~~deferred ~~note~~tax ~~holders.~~assets ~~The~~will ~~transaction~~not ~~was~~be ~~recorded as an increase in additional paid-in capital~~realized.

~~NOTE 6 – INCOME TAXES~~21

The provision ~~Company provides~~ for income taxes ~~under~~differs ~~ASC~~from ~~740 “Tax Provisions”. ASC 740 requires~~ the ~~use~~amounts ofwhich anwould ~~asset~~be ~~and~~provided ~~liability~~by ~~approach~~applying inthe ~~accounting~~statutory ~~for~~federal income ~~taxes. Deferred~~ tax ~~assets~~rate of ~~and~~35% ~~liabilities~~to ~~are~~net ~~recorded~~loss ~~based~~before onprovision ~~the~~for ~~differences~~income ~~between~~taxes ~~the~~for ~~financial statement and tax bases of assets and liabilities and~~ the ~~tax~~following ~~rates in effect when these differences are expected to reverse.~~reasons:

ASC 740 requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.

	For the year ended
	December 31,
	2017			2016
Income tax expense at statutory rate	$	(42,914	)	$	(14,180	)
Contributed services		-			1,411
Change in valuation allowance		42,914			12,769
Income tax expense per books	$	-		$	-

NOL carryover	$	(2,986,331	)	$	(2,943,417	)
Contributed services		2,652,102			2,652,102
Change in valuation allowance		334,229			291,315
Net deferred tax asset	$	-		$	-

~~The~~Due to ~~provision~~the ~~for~~change ~~income~~in ~~taxes~~ownership ~~differs~~provisions ~~from~~of the ~~amounts~~Tax ~~which~~Reform ~~would~~Act beof ~~provided~~1986, bynet ~~applying~~operating ~~the~~loss ~~statutory~~carry ~~federal~~forwards of $2,986,331 for federal income tax ~~rate~~reporting ofpurposes ~~34%~~are subject to annual limitations. Should a change in ownership occur net operating loss ~~before~~carry ~~provision~~forwards may ~~for~~be ~~income~~limited ~~taxes~~as ~~for~~to ~~the~~use ~~following~~in ~~reasons:~~future years.

	December 31, 2016			December 31, 2015
Income tax benefit (expense) at statutory rate	$	(14,180)	$		(216,058)
Contributed services		1,411			2,040
Change in valuation allowance		12,769			214,018
Income tax expense per books	$	-	$		-

Certain tax attributes are subject to an annual limitation as a result of the change of control as defined under Internal Revenue Code Section 382.

6 NOTE 7 – ~~INCOME~~ ~~TAXES (CONTINUED)~~SUBSEQUENT EVENTS

~~Net~~We reached ~~deferred~~a ~~tax~~settlement ~~assets~~with ~~consist~~Global ofon September 14, 2018, including a release, and had the ~~following~~Company’s ~~components~~transfer asagent issue 246,918 shares of: Common Stock to Global to satisfy the obligation.

	December 31, 2016				December 31, 2015
NOL carryover	$	(2,943,417	)	$		(2,929,237	)
Contributed services		2,642,531				2,642,531
Contributed Services		9,571				8,160
Valuation allowance		291,315				278,549
Net deferred tax asset	$	-		$		-

In accordance with ASC 855-10, Company management reviewed all material events through the date of this report and determined that there are no additional material subsequent events to report.

Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards of $8,657,109 for federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur net operating loss carry forwards may be limited as to use in future years.22

~~Certain~~Item 9. ~~tax~~Changes ~~attributes~~in ~~are~~and ~~subject~~Disagreements towith anAccountants ~~annual~~on ~~limitation~~Accounting asand aFinancial ~~result of the change of control as defined under Internal Revenue Code Section 382~~Disclosure.

~~NOTE 7 – CHANGE OF CONTROL~~None.

As reported on Schedule 14f, filed with the Securities and Exchange Commission on September 9, 2016, effective September 9, 2016, Deworth Williams, the principal stockholder of the Company (“Williams”), entered into a Stock Purchase Agreement (the “Agreement”), as amended (the “Amended Agreement”), dated, August 30, 2016, with Taylor Group Holdings, LLC (the “Buyer”), a Florida Limited Liability Company, pursuant to which, among other things, Williams agreed to sell to the Buyer, and the Buyer agreed to purchase from Williams, a total of 937,063 shares of Common Stock owned of record and beneficially by Williams (the“Purchased Shares”)Item 9A. ~~The~~ ~~Purchased~~Controls ~~Shares represented approximately 84.3% of the Company’s issued~~ and ~~outstanding shares of Common Stock as of the Record Date~~Procedures. In connection with the transactions contemplated by the Agreement, the Board appointed Una Taylor and Theodore Faison to fill vacancies on the Company’s Board of Directors, effective September 19, 2016.

~~NOTE 8 – SUBSEQUENT~~Evaluation of ~~EVENTS~~Disclosure Controls and Procedures

InAs of ~~accordance~~the end of the period covered by this annual report, management, with ~~ASC~~the ~~855-10~~participation of our chief executive officer and principal financial officer, ~~Company~~carried ~~management~~out ~~reviewed~~an ~~all~~evaluation ~~material~~of ~~events~~the ~~through~~effectiveness of the ~~date~~design and operation of ~~this~~our ~~report~~“disclosure controls and procedures”, as defined in the Securities Exchange Act of 1934, Rules 13a-15(e) and ~~there~~15-d-15(e). Based upon that evaluation, our principal executive officer and financial officer concluded that as of November 2017, and thereafter, our disclosure controls and procedures are nonot ~~other~~effective ~~material~~to ~~subsequent~~ensure ~~events~~that information required to ~~report.~~be disclosed by us in the reports that we file or submit under the Exchange Act is:

~~Item~~(i) recorded, 9.processed, ~~Changes~~summarized in and ~~Disagreements~~reported, ~~with~~within ~~Accountants~~the ontime ~~Accounting~~periods specified in the SEC’s rules and ~~Financial~~forms; ~~Disclosure.~~and

~~Not~~(ii) accumulated ~~applicable~~and communicated to our management, including our chief executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

~~Item~~Management has ~~9A.~~retained ~~Controls~~a CFO consulting service, a certified public accounting firm, and ~~Procedures~~legal counsel to bring systems up to compliance levels and to assure timely reporting as required by SEC rules.

~~Evaluation~~In designing and evaluating the disclosure controls and procedures, management recognizes that there are inherent limitations to the effectiveness of ~~Disclosure~~any ~~Controls~~system of disclosure controls and ~~Procedures~~procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their desired control objectives. Additionally, in evaluating and implementing possible controls and procedures, management is required to apply its reasonable judgment.

As of the end of the period covered by this annual report, management, with the participation of our chief executive officer and principal financial officer, carried out an evaluation of the effectiveness of the design and operation of our “disclosure controls and procedures”, as defined in the Securities Exchange Act of 1934, Rules 13a-15(e) and 15-d-15(e). Based upon that evaluation, our principal executive officer and financial officer concluded that as of December 31, 2016, our disclosure controls and procedures are not effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is:23

~~(i)~~Management’s Annual ~~recorded,~~Report ~~processed,~~on ~~summarized~~Internal ~~and~~Control ~~reported,~~Over ~~within~~Financial ~~the time periods specified in the SEC's rules and forms; and~~Reporting

~~(ii)~~Management is ~~accumulated~~responsible for establishing and ~~communicated~~maintaining toadequate ~~our~~internal ~~management,~~control ~~including~~over financial reporting for our ~~chief~~company. ~~executive~~Our ~~officer~~control system is designed to provide reasonable assurance regarding the reliability of financial reporting and ~~principal~~the preparation of financial statements ~~officer,~~for asexternal ~~appropriate,~~purposes toin ~~allow~~accordance ~~timely~~with ~~decisions~~U.S. ~~regarding~~generally ~~required~~accepted ~~disclosure~~accounting principles. Our internal control over financial reporting includes those policies and procedures that:

In● ~~designing~~pertain ~~and evaluating the disclosure controls and procedures, management recognizes that there are inherent limitations~~ to the ~~effectiveness~~maintenance of ~~any~~records ~~system~~that, ofin ~~disclosure~~reasonable ~~controls and procedures~~detail, ~~including~~accurately ~~the possibility of human error~~ and ~~the~~fairly ~~circumvention~~reflect ~~or overriding of~~ the ~~controls~~transactions and ~~procedures.~~disposition Aof ~~control~~our ~~system,~~assets; no● ~~matter how well conceived and operated, can~~ provide ~~only~~ reasonable, ~~not absolute,~~ assurance that the ~~objectives~~transactions ofare ~~the~~recorded ~~control~~as ~~system~~necessary ~~are~~to ~~met.~~permit ~~Further,~~preparation ~~the design~~ of athe ~~control~~financial ~~system~~statements ~~must~~in ~~reflect~~accordance ~~the~~with ~~fact~~generally ~~that~~accepted ~~there~~accounting ~~are~~principles ~~resource constraints~~ and ~~the~~that ~~benefits~~receipts ofand ~~controls~~expenditures ~~must~~are bebeing ~~considered~~made ~~relative~~only towith ~~their~~proper ~~costs.~~authorizations; ~~Accordingly, even effective disclosure controls~~ and ~~procedures~~● ~~can only~~ provide reasonable assurance ofregarding ~~achieving~~prevention ~~their~~or ~~desired~~timely ~~control~~detection ~~objectives.~~of ~~Additionally~~unauthorized acquisition, inuse ~~evaluating~~or ~~and~~disposition ~~implementing~~of ~~possible~~our ~~controls~~assets ~~and~~that ~~procedures,~~could ~~management~~have isa ~~required~~material toeffect ~~apply~~on ~~its~~the ~~reasonable~~financial ~~judgment~~statements.

~~Management’s~~Because of ~~Annual~~inherent ~~Report~~limitations, oninternal ~~Internal~~control ~~Control~~over ~~Over~~financial ~~Financial~~reporting ~~Reporting~~may not prevent or detect all misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management, including isour ~~responsible~~principal ~~for~~executive ~~establishing~~officer and ~~maintaining~~principal ~~adequate~~financial officer, assessed the effectiveness of our internal control over financial reporting ~~for~~as ~~our~~of ~~company~~December 31, 2017. ~~Our~~In ~~control~~making ~~system~~this isassessment, ~~designed~~management toused ~~provide~~the ~~reasonable~~criteria ~~assurance~~set ~~regarding~~forth by the ~~reliability~~ Committee of ~~financial~~Sponsoring ~~reporting~~Organizations ~~and~~of the ~~preparation~~Treadway ofCommission ~~financial~~(COSO) ~~statements~~in ~~for~~Internal ~~external~~Control ~~purposes~~Over inFinancial ~~accordance~~Reporting ~~with~~– UGuidance for Smaller Public Companies.S. ~~generally~~Based ~~accepted~~on ~~accounting~~our ~~principles.~~assessment ~~Our~~and those criteria, our management concluded that our internal control over financial reporting ~~includes~~was ~~those~~ineffective ~~policies~~as of April 1, 2017. Counsel, certified public accountants, and ~~procedures~~outside ~~that:~~consultants have been retained to bring reporting and internal controls up to standards.

●Changes in Internal Control over Financial Reporting

~~pertain~~There have tobeen ~~the~~no ~~maintenance~~significant ofchanges ~~records~~in our internal controls over financial reporting or in other factors that could materially affect, or inwould ~~reasonable~~be ~~detail~~likely to materially affect, ~~accurately~~our ~~and~~internal ~~fairly~~controls ~~reflect~~over ~~the~~financial ~~transactions~~reporting ~~and~~subsequent ~~disposition~~to ofthe date we carried out our ~~assets;~~evaluation.

●Item 9B. Other Information.

~~provide~~The registrant ~~reasonable~~must ~~assurance~~disclose ~~that~~under ~~the~~this ~~transactions~~item ~~are~~any ~~recorded~~information asrequired ~~necessary~~ to ~~permit~~be ~~preparation~~disclosed in a report on Form 8-K during the fourth quarter of the ~~financial~~year ~~statements~~covered inby ~~accordance~~this ~~with~~Form ~~generally~~10-K, ~~accepted~~but ~~accounting~~not ~~principles~~reported, ~~and~~whether ~~that~~or ~~receipts~~not ~~and~~otherwise ~~expenditures~~required ~~are~~by ~~being~~this Form 10-K. If disclosure of such information is made ~~only~~under this item, it need not be repeated in a report on Form 8-K which would otherwise be required to be Þled with ~~proper~~respect ~~authorizations;~~to ~~and~~such information or in a subsequent report on Form 10-K.

●The affirmed transactions in fourth quarter 2017, together with the others not yet reported on form 8-k in 2017, are discussed in Item 1, and the relevant documents showing same are listed at Part IV, Item 15 and are attached to this report.

~~provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.~~24

Because of inherent limitations, internal control over financial reporting may not prevent or detect all misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.PART III

12Item 10. Directors, Executive Officers and Corporate Governance.

Management, including our principal executive officer and principal financial officer, assessed the effectiveness of our internal control over financial reporting as of December 31, 2016. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (~~COSO~~a) Identification in Internal Control Over Financial Reporting – Guidance for Smaller Public Companies. Based on our assessment and those criteria, our management concluded that our internal control over financial reporting was ineffective as of ~~December~~Directors: ~~31, 2016.~~

~~Changes~~(i) Una inJ. ~~Internal Control over Financial Reporting~~Taylor

There have been no significant changes in our internal controls over financial reporting or in other factors that could materially affect, or would be likely to materially affect, our internal controls over financial reporting subsequent to the date we carried out our evaluation.Age: 43

~~Item~~Positions/Offices: Chief ~~9B.~~Executive ~~Other~~Officer, ~~Information.~~President, Secretary, Treasurer, Board Member

~~Not~~Term of ~~applicable.~~Office: Until successor is nominated and qualified

13Prior terms: Served from and after reorganization in 2016 until June 2017 as CEO and Board member.

~~PART~~Re-commenced Board ~~III~~and officer service November 2017.

~~Item~~Other contractual ~~10.~~arrangements: ~~Directors, Executive Officers and Corporate Governance.~~None

~~The~~(ii) Wajed ~~executive officers and directors of the Company are as follows:~~Salem

Name		Age		Position
Una Taylor		40		President, CEO, CFO and Director

Age: 57

~~Theodore~~Positions/Offices: Board ~~Faison~~Member

~~41 Director~~Term of Office: Until successor is nominated and qualified

~~All~~Prior terms: ~~directors~~Elected ~~hold office until the next annual meeting of stockholders and until their successors have been duly elected and qualified. There are no agreements with respect~~ to ~~the~~Board ~~election~~November of2017, ~~directors.~~renamed ~~We have not compensated current directors for service on the board of directors or any committee thereof. Directors are entitled~~ to besame reimbursed for expenses incurred for attendance at meetings of the board and any committee of the board. However, directors may defer expenses and/or take payment in shares of Protect common stock. As of the date hereof, no director has accrued any expenses or compensation. Officers are appointed annually by ~~the~~Shareholder ~~Board~~action ofwithout ~~Directors and each executive officer serves at the discretion of the board. Presently we do not have any standing committees.~~meeting

~~No director~~January 30, officer or affiliate has, within the past five years, filed any bankruptcy petition, been convicted in or been the subject of any pending criminal proceedings, or is any such person the subject or any order, judgment, or decree involving the violation of any state or federal securities laws2019.

~~Currently,~~Other contractual ~~there~~arrangements: is no arrangement, agreement or understanding between management and non-management stockholders under which non-management stockholders may directly or indirectly participate in or influence the management of our affairs. Present management openly accepts and appreciates any input or suggestions from stockholders. However, the board of directors is elected by stockholders and the stockholders have the ultimate say in who represents them on the board. There are no agreements or understandings for any officer or director to resign at the request of another person and none of the current offers or directors are acting on behalf of, or will act at the direction of any other person.None

~~The~~Item 405: ~~following~~Section ~~sets~~16 ~~forth~~Reporting ~~the business experience of our directors, including specific qualifications to serve as director in light of our business:~~Persons

Una ~~Taylor~~ J. ~~Ms.~~ Taylor ~~has~~is ~~been~~an ~~the~~owner ~~Founder and CEO~~ of ~~Renewable~~more ~~Energy~~than ~~Supplies~~10% ~~LLC,~~of athe ~~Florida limited liability~~ company’s ~~for~~shares, ~~the last seven years. Renewable Energy Supplies LLC was founded in 2010~~ as ~~an Alternative Energy Company with the goal~~ of ~~bringing~~November ~~renewable~~2017, ~~non-polluting~~and ~~power~~is tosubmitting ~~homes~~SEC ~~and~~Form ~~businesses~~5 in ~~the~~compliance with ~~Caribbean~~SEC ~~region.~~Section ~~Six~~16 ~~years~~requirements ~~later,~~along ~~Renewable~~with ~~Energy~~this ~~continues~~10-k ~~to deliver the best products, training~~ and ~~support~~other ~~needed to its growing customer base. Renewable Energy supplies re~~catch-~~sellers,~~up ~~contractors,~~financial ~~integrators,~~ and ~~installers~~substantive ~~with~~reporting reliable products and the training they need to design, install and maintain renewable energy systems. Ms. Taylor also serves as a director of World Cup of Sales Inc. (an online cash prize sales tournament for ~~college students that help startups launch their products) and served as its first Chief Product Officer. In addition, Ms. Tayler is a member of~~ the ~~Board~~period ofafter Q2 ~~Directors of Eight Dragons Company, a Nevada public corporation, and serves as its President and Chief Executive Officer~~2017.

~~Theodore~~Item 407 Faison. Mr. Faison has been Co-Founder, Strategy Officer, and Board Chairman at World Cup of Sales, a product market fit and sales platform geared towards startup companies and product launches, since December 2015. Since March 2003, he has been an employee of IBM. His specific recent employment with IBM includes being a Rational Channel Sales Manager, from 2011 to 2013, a member of the IBM North America Software Partner Representative & Ecosystem Development team from 2013 to 2015, the Worldwide Trusteer Advanced Fraud Protection Channel Sales Leader from January 2015 to January 2016 and since January 2016 being responsible for Strategic Embedded Solution Partnerships for IBM Analytics. He has more than 15 years in software sales, channel sales, and business development, having personally delivered consulting, training, and sales interactions to over 1,000 customers (~~of all sizes and spanning many industry verticals~~e)~~. His~~: ~~leadership~~Compensation experience include leading a global channel sales team, building a channel ecosystem for a $2B IBM Security acquisition (Trusteer), and managing some of the industry's largest software channel resellers. In addition, Mr. Faison is a member of the Board of Directors of Eight Dragons Company, a Nevada public corporation. Committee

~~Committees~~None. Una J. Taylor owns 93% of the ~~Board~~voting power of ~~Directors~~all stock in the company, and the rest is closely held. Within the limits of state law providing appraisal and dissenter’s rights, if any, she may determine any transaction and set any compensation level wished, and no committee process is needed or appropriate.

~~Currently we do not have any standing committees of the board of directors~~Item 11. ~~Until~~Executive such time as formal committees are established, our board of directors will perform some of the functions associated with a nominating committee and a compensation committee, including reviewing all forms of compensation provided to our executive officers, directors, consultants and employees, including stock compensationCompensation. ~~The board will also perform the functions of an audit committee until we establish a formal audit committee.~~

~~Code~~No compensation ofwas ~~Ethics~~deferred or accrued in 2017, since company lacked cash flow.

WeItem 12. ~~have~~Security ~~not~~Ownership ~~adopted a Code~~ of ~~Ethics~~Certain ~~and~~Beneficial ~~Business~~Owners ~~Conduct applicable to our directors~~ and ~~employees,~~Management ~~including our principal executive officer, principal financial officer, principal accounting officer~~ and ~~controller,~~Related orStockholder ~~persons performing similar functions~~Matters. ~~We anticipate that we will adopt a Code of Ethics in the future.~~

~~Compliance~~No non-employee ~~With~~stock ~~Section~~compensation ~~16(a)~~plans ofare ~~the~~now ~~Exchange~~in ~~Act~~effect, and no employee plan provides any stock issuance rights.

~~Section~~Item 13. ~~16(a)~~Certain ofRelationships ~~the Exchange Act requires our directors~~ and ~~executive~~Related ~~officers~~Transactions, and ~~persons~~Director ~~who own more than 10% of our common stock, to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock and other equity securities~~Independence. ~~We believe that no reports were filed during the fiscal year 2016.~~

Item 404: 11No related party transactions apart from a related party payable due to Una J. ~~Executive~~Taylor ~~Compensation~~for expenses paid on behalf of the Company in the first quarter of 2017.

14Item 407(a) of Regulation S-K: There are no independent directors.

~~Currently,~~Item 14. ~~our~~Principal ~~directors~~Accounting doFees ~~not~~and ~~receive compensation for their services to the Company~~Services.

~~Item~~We do ~~12.~~not ~~Security~~have ~~Ownership~~an audit committee and as a result, our entire board of ~~Certain~~directors ~~Beneficial~~performs ~~Owners~~the duties of an audit committee. Our board of directors will approve in advance the scope and ~~Management~~cost of the engagement of an auditor before the auditor renders audit and ~~Related~~non-audit services. ~~Stockholder~~As ~~Matters~~a result, we do not rely on pre-approval policies and procedures.

~~The following table sets forth information regarding the beneficial ownership of our shares of common stock by:~~25

~~● each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock;~~Audit Fees

●The ~~each~~aggregate fees for professional services rendered by the Company’s independent auditors, Montgomery Coscia Greilich LLP in relation to 2017 and Sadler Gibb & Associates in relation to 2016, for the audit of ~~our~~the ~~directors;~~Company’s annual financial statements and review of quarterly financial statements in connection with the regulatory filings were $15,000 and $10,000, respectively.

~~● our executive officers; and~~Audit-Related Fees

●For the byyear ~~all~~ended ~~directors~~December 31, 2017 and ~~executive~~2016, ~~officers~~no asfees awere ~~group~~billed for assurance and related services by Montgomery Coscia Greilich LLP in 2017 or Sadler Gibb & Associates in 2016 which were not reported under the caption “Audit Fees” above.

Beneficial ownership is determined in accordance with SEC rules. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares of common stock subject to options or warrants held by that person that are currently exercisable or will become exercisable within 60 days after the date of this report, are deemed outstanding, but those shares are not deemed outstanding for purposes of computing percentage ownership of any other person. The number and percentage of shares beneficially owned are based on 1,111,460 shares of common stock outstanding as of March 31, 2016 and reflects the reverse stock split effected in November 2014. Each person named in the table has sole voting and investment power with respect to all shares shown as beneficially owned by that person, subject to community property laws, where applicable. Tax Fees

Name and Address	Amount and Nature of			Percent
of Beneficial Owner	Beneficial Ownership			of Class(1)
Directors and Executive Officers
Una Taylor		937,063			84.3%
95 Merrick Way, Third Floor, Coral Gables, Florida 33143
Theordoe Faison			0		0%
95 Merrick Way, Third Floor, Coral Gables, Florida 33143
All directors and officers		937,063			84.3%
a group (2 persona)

For the year ended December 31, 2017 and 2016, no fees were billed for tax compliance, tax advice, and tax planning by Montgomery Coscia Greilich LLP in 2017 or Sadler Gibb & Associates in 2016.

~~Note:~~All Other ~~Unless otherwise indicated, we have been advised that each person above has sole voting power over the shares indicated above.~~Fees

~~(1)~~The Company ~~Based~~did ~~upon~~not ~~1,111,460~~pay ~~shares~~any other fees in each of ~~common~~the ~~stock~~last ~~outstanding~~two onfiscal ~~March~~years ~~31,~~for products and services provided by the Montgomery Coscia Greilich LLP in 2017 or Sadler Gibb & Associates in 2016, other than the services reported in Audit Fees above.

~~Item 13. Certain Relationships and Related Transactions, and Director Independence.~~26

Since the beginning of the Company’s last fiscal year, to the best knowledge of the Company there was no person who had or has a direct or indirect material interest in any transaction, or proposed transaction to which the Company was or is a party.PART IV

Item 14 15. ~~Principal~~Exhibits, ~~Accounting~~Financial ~~Fees~~Statement ~~and Services~~Schedules.

We do not have an audit committee and as a result our entire board of directors performs the duties of an audit committee. Our board of directors will approve in advance the scope and cost of the engagement of an auditor before the auditor renders audit and non-audit services. As a result, we do not rely on pre-approval policies and procedures.

Exhibit No.		Exhibit Name

3.1*		Articles of Incorporation
3.2*		Certificate of Amendment – Capitalization Change
3.3*		Certificate of Amendment – Name Change 2006
3.4*		Certificate of Amendment – Name Change 2010
3.5*		By-Laws
4.1*		Instrument defining rights of holders – Specimen Stock Certificate
4.2**		Certificate of Amendment – Share Authorization
14.1***		Financial Code of Ethics
31.1		Certificate of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley act of 2002
31.2		Certificate of Principal Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley act of 2002
32.1		Certificate of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley act of 2002
32.2		Certificate of Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley act of 2002
101 INS		XBRL Instance Document
101 SCH		XBRL Taxonomy Extension Schema Document
101 CAL		XBRL Taxonomy Calculation Linkbase Document
101 DEF		XBRL Taxonomy Extension Definition Linkbase Document
101 LAB		XBRL Taxonomy Labels Linkbase Document
101 PRE		XBRL Taxonomy Presentation Linkbase Document

Audit Fees

*	Previously filed as exhibit to Form 10 filed on June 8, 2010.
**	Previously filed as exhibit to Form 10-Q filed on February 7, 2019.
***	Previously filed as exhibit to Form 8-K filed on September 20, 2016.

~~The aggregate fees billed by our independent auditors, Sadler, Gibb & Associates, L~~Item 16.~~L.C.,~~ ~~for~~Form ~~professional services rendered for the audit of our annual financial statements included in our annual reports for the years ended December 31, 2016 and 2015 were $~~10~~,000~~–K ~~for each year~~Summary.

~~Audit~~No summary ~~Related Fees~~provided.

For the year ended December 31, 2016 and 2015, there were no fees billed for assurance and related services by Sadler, Gibb & Associates, L.L.C. relating to the performance of the audit of our financial statements which are not reported under the caption "Audit Fees" above.27

~~Tax Fees~~SIGNATURES

~~For~~Pursuant to the ~~years~~requirements ~~ended~~of ~~December~~Section ~~31,~~13 ~~2016~~or ~~and~~15(d) ~~2015,~~of nothe ~~fees~~Securities ~~were~~Exchange ~~billed~~Act byof ~~Sadler~~1934, ~~Gibb~~the &registrant ~~Associates,~~has ~~L.L.C.~~duly ~~for~~caused ~~tax~~this ~~compliance,~~report to ~~tax~~be ~~advice~~signed ~~and~~on ~~tax~~its ~~planning~~behalf by the undersigned, thereunto duly authorized.

We(Registrant) Protect doPharmaceuticals not use Sadler, Gibb & Associates, L.L.C. for financial information system design and implementation. These services, which include designing or implementing a system that aggregates source data underlying the financial statements or generates information that is significant to our financial statements, are provided internally or by other service providers. We do not engage Sadler, Gibb & Associates, L.L.C. to provide compliance outsourcing services.Corporation

~~The~~By: ~~board~~/s/ ofUNA ~~directors~~TAYLOR ~~has~~Una ~~considered~~Taylor ~~the~~Chief ~~nature~~Executive and amount of fees billed by Sadler, Gibb & Associates, L.L.C. and believes that the provision of services for activities unrelated to the audit is compatible with maintaining Sadler, Gibb & Associates, L.L.C.’s independence.Officer

17Date: February 15, 2019

~~PART 1V~~Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

~~Item~~By: ~~15.~~/s/ ~~Exhibits,~~UNA ~~Financial~~TAYLOR ~~Statement~~Una ~~Schedules~~Taylor Chief Executive Officer (a)Principal ~~Exhibits~~Accounting Officer)

18Date: February 15, 2019

19By: /s/ UNA TAYLOR Una Taylor Chief Executive Officer (Principal Executive Officer)

~~SIGNATURES~~Date: February 15, 2019

~~Pursuant~~Supplemental Information to ~~the~~be ~~requirements~~Furnished ofwith ~~Section~~Reports 13Filed orPursuant to Section 15(d) of the ~~Securities Exchange~~ Act ofby ~~1934,~~Registrants ~~the~~Which ~~registrant~~Have ~~has~~Not ~~duly~~Registered ~~caused~~Securities Pursuant ~~this report~~ to beSection ~~signed~~12 onof ~~its behalf by~~ the ~~undersigned, thereunto duly authorized.~~Act

Protect Pharmaceutical Corporation
	By:	/S/ UNA TAYLOR
		Chief Executive Officer
		Chief (Principal) Accounting Officer
		Dated: March 31, 2017

No annual report was provided to security holders.

~~Pursuant~~No proxy tostatements ~~the~~were ~~requirements~~sent ofto ~~the~~security ~~Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated~~holders.

Signature	Title	Date
/S/ UNA TAYLOR	Chief Executive Officer,	March 31, 2017
Una Taylor	Chief Principal Accounting Officer, Director
/S/ THEODORE FAISON	Director	March 31, 2017
Theodore Faison

Filing Compare · PROTECT PHARMACEUTICAL Corp